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A  constant of the Heckel equation indicating the intercept 
Ac  activity of the enzyme 
A420  Absorption at 420 nm 
B  constant of the Heckel equation indicating the extent of particle rearrangement 
b1, b2  intercept 
C  proportionality constant of the modified Heckel equation 
D  diameter 
Ew  initial weight 
K  constant of the Heckel equation indicating the slope 
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n  number 
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pb  bonding probability 
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S  surface 
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Vt  true volume 
Vtot  apparent volume 
w  weight 
 
 
 
 
 
 
 
Symbols and Abbreviations 
 VI  
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1 Summary 
 
This thesis is based on the investigation of the compression behavior of a solid model enzyme. It 
was the scope of this work to characterize the behavior of the enzyme powder under pressure to 
gain on the one hand information about the behavior of powder during the compression process 
and on the other hand to get more knowledge about the behavior of enzyme powder in 
pharmaceutical formulations. An important aspect was the influence of excipients because their 
deformation character may change the properties of pharmaceutical formulations. For that reason 
the physical influences of a plastic and a brittle model excipient, respectively on the enzyme 
powder in binary mixtures was investigated. Critical mixture ratios should be defined where the 
behavior of the binary mixtures shows sudden changes. If critical mixture ratios are known, they 
can be avoided in the development of dosage forms to get robust formulations. Since the direct 
compaction of powders may be difficult, the compression behavior of enzyme granulates and 
enzyme coated pellets was investigated as well. For that reason powders and pellets from different 
raw materials were layered with an enzyme binding agent solution. The enzyme activity of the 
various granulates, pellets and compacts was detected and the preparations were judged based on 
this property.  
 
The investigated model enzyme was a solid β-galactosidase preparation from Aspergillus oryzae, 
which was chosen for its stability, the molecular weight of 105 kDa, which is an average value 
compared to other enzymes and the reliable and relatively simple enzyme activity assay.  
 
Compacts were produced on a material testing machine and the activity was detected 
spectophotometrically. The compression properties of the various formulations were characterized 
by using Heckel equation and modified Heckel equation. Granulates and pellets as well as their 
compacts were further characterized by scanning electron microscopy pictures.  
 
The extent of activity loss in the compacted brittle enzyme powder could not be decreased by the 
addition of a plastic or a brittle excipient. With the diversity of the particles even a higher number of 
shearing forces was built in the compacts during compression. The shearing forces seemed to 
have negative influences on the activity of the enzyme. In the binary powder mixtures of the 
enzyme powder with the plastic excipient there was found a sudden change in the behavior of the 
system at a mixture ratio of 20% of enzyme powder. For the brittle-brittle binary mixtures of the 
enzyme powder with an excipient, differences in the behavior were difficult to detect because the 
two powders showed a very similar behavior. Tendencies towards a critical concentration at a ratio 
of 60% (V/V) of enzyme powder could not be proved, although a comparison with a second brittle 
enzyme powder preparation in mixtures with a brittle excipient showed similar tendencies. It was 
found that a plastic compression character and regularity in shape and size of the compressed 
particles was important to protect the enzyme activity under pressure. These properties could be 
reached with the production of granulates and the coating of pellets by enzyme layering, whereas 
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especially the compacted enzyme coated pellets showed no significant activity loss under pressure 
due to the very regular shape and size distribution and the fact that the pellets did not break and 
only slightly changed their shape to reduce the spaces between the individual pellets.  
 
A lot of new aspects in the field of particle compression have been discussed in this work. It was 
found that the shape and the size of the various particles may have big influences on friction and 
shearing forces. Shearing forces can cause a reduction of enzyme activity during the compression 
of an enzyme powder. The compression character of the particles showed influences on the extent 
of activity loss under pressure, whereas plastic properties are favorable to protect the enzyme.  
 
As a further step it would be important to test the transferability of the results on other enzyme 
products and to take into consideration more practical aspects like the production on a rotary press, 
the investigation of economic points of view or simply the attainment of a required dosage to define 
an optimal formulation for an oral application of a pharmaceutical enzyme powder.  
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2 Introduction 
 
Today there are a lot of different, partly very special dosage forms on the market. In this wide range 
of possibilities of drug dispensation, tablets are still the most common used dosage form. The 
importance of this quite old dosage form is evident looking at the development of tablets since the 
invention of a manual tablet press in 1843. Besides the standard tablets there exists also a great 
number of special tablet modifications, for example effervescent, film, matrix and chewing tablets 
that are used to influence the drug absorption. The popularity of tablets can be well explained. First 
of all, the application of oral dosage forms is of great importance because it is easy and safe. In 
addition tablets show metering accuracy, robustness and stability and their production is economic.  
 
Looking at the big number of tablets on the market – about 48% of all drugs sold per year are 
tablets – it seems that the development and production process of a tablet is well known and easy. 
But in fact it is a matter of a very complex process. The simple compression of a bulk material, 
either powder or granulate, to a robust tablet is dependent on a great number of influences, mainly 
force transfer, particle deformation and the formation of adhesive forces. Therefore the behavior of 
powder under compression is an interesting topic of wide range. Although a lot of work has already 
been done on this topic (Leuenberger et al., 1981; Leuenberger, 1982; Jetzer et al., 1983; Kuentz 
and Leuenberger, 2000), it is still not known enough on it. Compression behavior and thus tablet 
properties depend on the different powders used. As tablet excipients as well as drugs have very 
different properties, it is quite difficult to make general statements about their compression 
behavior. For pharmaceutical application there are very complex tablet ingredient mixtures and it is 
still impossible to preview the properties of the end-product tablet only by knowing the exact 
composition of the powder mixture. Achieving the possibility of such predictions would be economic 
and time saving. For this reason the characterization of model excipients and drugs as well as 
several mixtures of them is an interesting and important research field. 
 
The process of powder compression can be mathematically described. Celik (1992) and Hiestand 
(1997) give an overview of this complex process in their work. A further approach to describe the 
behavior of powder and powder mixtures under compression is the application of percolation 
theory, which has a long tradition at the Institute of Pharmaceutical Technology in Basel. Different 
examples illustrate the successful application of percolation theory in the field of pharmaceutical 
powder technology. Percolation theory provides key tools for a more rational design of 
pharmaceutical dosage forms and for the development of robust formulations. Percolation theory 
defines a percolation threshold, or in other words a critical concentration of a component in a binary 
or more complex powder mixture. It is evident that the critical concentration of a component in a 
tablet formulation is the source of lack of robustness of a formulation. Therefore it is important for a 
robust formulation that the relevant concentration of a component in a tablet formulation is not too 
close to the critical concentration and thus robustness of the formulation is guaranteed also with 
slight changes in the proportions of components during scale-up and large scale production of 
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tablet formulations. The investigation of compression processes, behavior of powder and powder 
mixtures under compaction and the application of percolation theory leads to a definition of robust 
formulations which can be used as standard formulations to enable a more rational design of 
pharmaceutical dosage forms.  
 
The fact that the complexity of drug substances is increasing, can also lead to difficulties in the 
development of new tablet formulations. Among other new drug substances the use of proteins and 
peptides as pharmaceuticals is steadily increasing, especially with the fast development of 
biotechnological processes. Isolation, purification, formulation and delivery of proteins represent 
significant challenges to pharmaceutical scientists, as proteins possess unique chemical and 
physical properties. These properties pose difficult stability problems, which can be influenced by 
the formulation and technological factors, for example excipients, temperature, storage conditions, 
compression or shearing forces. Manning et al. (1989) give an overview of the stability of protein 
pharmaceuticals.  
Investigation of protein pharmaceutical behavior in tablet formulations can be done by the use of 
enzymes as model proteins. The enzyme activity can be quantified. It is known to decrease under 
pressure and can thus be used as indicator of changes, which occur during compression.  
 
The scope of this thesis is the investigation of enzyme powder under compression to gain on the 
one hand more knowledge about powder compression and tablet formulation in general and on the 
other hand to get information on behavior of enzyme powder in pharmaceutical formulations. An 
important aspect is the influence of excipients, because the deformation character of an excipient 
can of course determine the tablet properties. In addition possible chemical and physical interaction 
between excipients and the investigated model enzyme powder β-galactosidase is an important 
part of this work. It is possible to classify common tablet excipients into plastic and brittle 
substances. One could imagine that the physical interaction in powder mixtures of a plastic 
excipient and the enzyme powder is different to that of a powder mixture with a brittle excipient. 
The classification of all powders and mixtures of them is done in this work with the application of 
Heckel equation and modified Heckel equation. A protecting effect of a plastic material on the 
sensitive enzyme drug is expected. Besides the investigation of the influence of plastic and brittle 
excipient powders, the aim is also to find out if there is a mixture range in which the enzyme 
powder is protected by the excipient in binary mixtures. Percolation theory is applied to define the 
critical enzyme concentration in these binary mixtures and thus find a robust formulation that can 
be used as standard formulation. A small digression is dedicated to the comparison with a second 
enzyme powder preparation, which is shortly before its launch to market as a pharmaceutical 
product.  
In the practice of powder compression and production of tablets there can rarely be found direct 
powder compaction. Thus it is a further part of investigation to produce granulates and coat pellets 
to find on the one hand the influences of the granulation process and the pellet coating on the 
enzyme activity and on the other hand to see if there are differences in the enzyme behavior under 
compression within these enzyme preparations. A possible protecting effect of the compacted 
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pellets with their smooth surface and the regularity of the particle size on the enzyme activity is 
investigated. For the production of granulates and the pellet coating there is also made the 
differentiation between plastic and brittle excipients.  
A comparison of all that different formulation methods and their influence on enzyme activity is 
done to make a proposal for an optimum robust formulation for an oral application of a 
pharmaceutical enzyme powder.  
Introduction 
 6  
 
 
Theoretical Section 
 7 
3 Theoretical Section 
 
3.1 Compression process 
 
The compression of particles and granules as a function of the applied pressure can be described 
by two different properties of the particulate matter: I the compressibility, i.e. the consolidation 
behavior of powder materials and II the compactibility, i.e. the measure of tableting performance. 
The compression process represents the concentration of free solid particles (powder) or 
agglomerates (granulate) under pressure into a mostly porous solid body of defined shape and 
sufficient mechanical strength.  
Basic statements about the compression process are in general valid for powders and granulates 
as well. The bulk material granulate is more coarse than a powder. It is a product of agglomerated 
powder and has several advantages regarding the compression of tablets. The production of a 
granulate from a powder results in an improvement of flowability, reduction of the specific surface 
and a better dissolution of the drug and is often leading to a better compactibility. Nevertheless the 
definition of powder and granulate is often arbitrary. 
 
Powder in a die, ready for compression is in a way a special case of a solid dispersion in gaseous 
state. The difference to an aerosol is founded in the fact that the particles are not isolated but keep 
contact in the whole bulk material. That kind of contact is not only a consequence of gravity and the 
limitation by the die wall, but especially of the force of attraction between the particles.  
 
The tensile strengths, the shear strengths and the elastic moduli of compacted substances 
influence the process of powder compression. The parameters mentioned were reduced to 
dimensionless parameters by Hiestand and Smith (1984) to quantify and evaluate tableting 
performance. The bonding index is the ratio of the tensile strength to the dynamic indentation 
hardness and is interpreted as indicating the relative survival during decompression of the areas of 
true contact that were built at maximum compression. The strain index indicates the relative strain 
energy developed during the elastic recovery following the deformation. The brittle fracture index is 
an indicator of the brittleness of the compact. These indices can be used for comparison of the 
compression properties of powders.  
 
In the following chapters the stages of uniaxial compression are described as well as the bonding 
forces and the deformation process that result during compression. A further important aspect is 
the density distribution in tablets and the porosity and relative density of compacts that are also 
described mathematically by pressure porosity equations. Furthermore special aspects of 
compression processes, i.e. pellet and enzyme compression are mentioned.  
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3.1.1 Uniaxial compression 
 
The compaction of tablets is in the practice of the pharmaceutical industries an uniaxial 
compression process. The free particles that are filled in a die get condensed by applying force 
with a lower and an upper punch. The aim of this condensation is the formation of a compressed 
core with a definite shape, which has the new properties of a solid body (Sucker et al., 1991a). 
The process that runs through in die during compression was explained by Train (1956). He 
investigated the relationship between the applied pressure and the relative volume of the powder 
accumulation in the die. Train found that there was no linear behavior in that relationship but 
changes in slope of the curve of applied pressure versus relative volume. According to Train the 
compression process can therefore be classified into four stages.  
 
Stage I:  A decrease in the relative volume is caused by interparticulate slipping of the 
powder, which leads to a closer packing. With the overcoming of the friction forces 
particles slide to energetically convenient positions. The process is limited by 
reaching the densest packing because the particles become immobile relative to 
one another.  
 
Stage II: With the immobility of the particles a formation of temporary struts, columns and 
vaults results. These structures protect small voids and support generally the 
imposed load.  
 In case of cohesive powders, this low state of consolidation may be sufficient to 
create a loose compact as known from the filling of hard gelatine capsules.  
 
Stage III: A higher compact strength causes a destruction of the structure of Stage II. The 
consequence is a deformation of the particles, either by crushing or by plastic 
flowing.  
 This behavior results because there are point and line contacts between the rough 
surfaces of the particles. The applied stresses are transmitted from particle to 
particle through these contacts. As the surface area in contact is small compared to 
the entire surface area of the bulk, high stresses are imposed locally causing the 
material to fail. With the failure of the structure, new surfaces are built and the 
stress distribution is more homogeneous and new bonds are built. 
 
Stage IV: When the structure formed is strong enough to support the imposed load, any 
further reduction in volume of the compact involves the normal compressibility of 
the solid material. Any further decrease in the voids of a still porous compact can 
only be achieved either by exceeding the crushing strength of the structure or by 
plastic deformation, or both.  
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An elastic re-extension is resulting, when the force is taken off the system after the compression. 
The degree of re-extension is depending on the character of the substance.  
The four stages of the compression process are shown in Fig. 3.1. 
 
 
 
Stage I Stage II 
Stage III Stage IV 
 
 
Fig. 3.1: Schematic illustration of stages I to IV of the compression process. 
 
 
According to that description the transition between powder and tablet takes place in the third stage 
of compression. Yet it is important to mention, that this classification into four stages is very 
schematic and it must be considered that the different stages do not occur homogeneously in the 
compressed core. Different zones in the compressed core can be in different stages at the same 
time due to the inhomogeneous pressure distribution and in addition, due to the different substance 
properties, if the compressed core is built of a powder mixture. Nevertheless, the four stages 
postulated by Train are still considered as standard description of the uniaxial compression 
process.  
 
 
3.1.2 Bonding in tablets 
 
The mechanical strength of a compact is a consequence of the augmentation of the adhesive 
power resulting from the particle arrangement during the compression process. It is not only the 
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number of contacts between particles that increases during the compression process but also the 
deformation, which contributes to the strengthening of the adhesion. 
There are three types of interparticle adhesion mechanisms that are of significance in tablet 
formation (Nyström et al., 1993): 
 
Solid bridges 
 
Mechanical interlocking 
 
Intermolecular forces 
 
Solid bridges result from recrystallisation or melting and solidification. However, these two 
phenomena can only appear in very special cases. For example a partly melting on so called hot 
spots caused by plastic flowing (Bowden and Tabor, 1958) or dissolution in adsorbed water. For 
that reason the solid bridges do only play a small role concerning the bonding in tablets.  
 
Mechanical interlocking is dependent on the shape and the surface of the particles and their 
deformation during compression. It is possible that with very irregular surfaces interlocking between 
particles is built but the relevance for bonding in tablets is small.  
 
Finally, the intermolecular forces are considered most important for mechanical strength in tablets. 
Intermolecular forces is a collective term for all bonding forces that act between surfaces separated 
by some distance. The term summarizes van der Waals forces, electrostatic forces and hydrogen 
bonding (Israelachvili, 1985). The term Van der Waals forces again include three different forces 
between atoms and molecules, i.e. dipole-dipole interaction (Keesom interaction), dipole-induced 
dipole interaction (Debye interaction) and the dispersion forces (London interaction). 
The London interaction is an electrostatic force that affects non-polar molecules and it contributes 
the main part to the overall cohesivity in tablets with an amount of 75 to 100% (Wray, 1992) if the 
tablet consists of a high amount of an active substance, as active substances are usually rather 
hydrophobic. In case of a tablet with an extremely potent drug substance with e.g. 0.5 mg drug 
substance in a formulation with e.g. 100 mg lactose as a hydrophilic diluent representing more or 
less 80% (m/m), all types of van der Waal forces are contributing to the cohesive strength of the 
tablet.  
 
 
3.1.3 Deformation process 
 
In Stage III of the compression process described above, the concentration of the particles causes 
a deformation. The type of deformation can be classified and is substance-dependent.  
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The loading of a solid results in a first phase in an elastic deformation. The change in the shape of 
the solid is reversible after relief and the solid regains his natural formation. Exceeding the linear, 
elastic range by applying more compression pressure ends in an irreversible deformation. The 
transition between reversible and irreversible deformation is called yield point. The irreversible 
deformation can be either a plastic deformation or a destructive deformation, i.e. a brittle fracture.  
 
 
 
strain strain 
plastic substance brittle substance 
st
re
ss
 
st
re
ss
 
 
 
Fig. 3.2: Stress-strain diagram (Sucker et al., 1991b). 
 
 
The stress-strain diagram (Fig. 3.2) shows the behavior of a substance under pressure. Plastic 
materials demonstrate a plastic flowing after the yield point, which finally ends in a fracture of the 
deformed particle. Brittle materials at the contrary do not have a plastic range, the elastic 
deformation is directly followed by a brittle fracture.  
 
Fig. 3.3 gives a schematic overview of the three deformation behaviors.  
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Fig. 3.3: Schematic illustration of the typical deformation behavior before, during and after 
application of a compressional strength.  
 
 
3.1.4 Density distribution in tablets 
 
Normally, a tablet is considered as a homogenous body. Yet, an exact examination of the compact 
exhibits heterogeneity in the density distribution (Train, 1956). Various density patterns can be 
observed depending on different compression conditions, for example the use of lubricant during 
compression, the shape of the tablet or the type of tablet press used. Stresses are transmitted 
through the material along force chains that make up a network of particle contacts and involve 
only fractions of all particles (Mueth et al., 1998). Nevertheless, in general it can be stated, that - 
talking about plane tablets and the use of an excenter press - there are regions of high densities in 
the center of the compact and on the upper edges. The lower edges of the tablet show 
comparatively low densities (Fig. 3.4). This result is also confirmed by Aydin et al. (1996). 
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Fig. 3.4: Density distribution in a tablet, cross section (Kandeil et al., 1977). 
 
 
3.1.5 Relative density and porosity of compacts 
 
Although a tablet is a heterogeneous body concerning the density distribution, the relative density 
and thus porosity of a compact is considered as an averaged property.  
Usually, the volume of the entire tablet Vtot (i.e. the apparent volume) is calculated from the 
measured height and the area of the compact. The determination of these dimensions is normally 
done when the compression process is finished and the tablet is ejected. This kind of measurement 
is called zero-pressure or out-of-die determination. The so-called apparent density, ρa is 
determined by division of the tablet weight m by the apparent volume, Vtot. The apparent density 
includes pores contrary to the true density ρtr where voids are excluded. The relative density ρr is 
obtained by dividing the apparent density by the true density: 
 
tot
t
tr
a
r V
V
==
ρ
ρρ         (3.1) 
 
The parameter Vt characterizes the true volume of the solid particles and therefore Eq. (3.1) shows 
that the relative density is essentially a solid fraction. This volume fraction, which is occupied by the 
solid, is linked to the volume fraction of the voids, i.e. the porosity ε. 
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VV ρε −=−=−= 11        (3.2) 
 
The porosity is often specified in percent. 
 
 
3.1.6 Heckel equation 
 
To describe the compression characteristics of powders, the most frequently used equation was 
postulated by Heckel (1961a,b) and was originally developed for metallic powders. The same 
equation was independently postulated earlier by Shapiro and Kolthoff (1947). Heckel equation 
describes the relationship between the porosity of a compact and the applied pressure and is 
based on the assumption that the densification of the bulk powder in-die follows the first order 
kinetics: 
 
AK
r
+=
−
σ
ρ1
1ln         (3.3) 
 
where ρr is the relative density of the compact at pressure σ. The constants A and K are 
determined analytically from the intercept and slope, respectively, of the extrapolated linear region 
of a plot of ln(1/(1-ρr)) versus σ. The intercept A is related to a starting density ρ0 and an arbitrary 
constant B that provides a measure of volume reduction by particle rearrangements: 
 
BA +



−
=
01
1ln
ρ
        (3.4) 
 
At lower pressures, there can always be shown a curved region, resulting from particle movement 
and rearrangement processes before interparticle bonding becomes appreciable (Fig. 3.5). 
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compaction pressure σ
 
 
Fig. 3.5: Schematic illustration of a Heckel plot (Heckel, 1961b). 
 
 
The linear region of the Heckel plot, i.e. shown at higher pressures, indicates the plastic 
deformation. Thus, K appears to be a material constant. Soft, ductile powders have higher K values 
than hard, brittle powders. This descriptive property of the constant K for deformation behavior of 
the material leads to the following correlation between K and the yield strength (Heckel, 1961a,b): 
 
y
K
σ3
1
≅          (3.5) 
 
where σy is the yield pressure. Although Heckel (1961a) only applied pressures between 69 and 
690 MPa, he postulated that extrapolation of the values to even higher pressures are justified, 
because linearity exists over nearly 80% of the pressure range. Contrary to that statement, it has 
often been seen that at high pressures the curvature of the Heckel plot arises quite exponentially. 
This fact is very visible with plotted data from in-die measurement. In-die or at-pressure 
measurements are often made to get more data in a faster way, but results can be influenced by an 
elastic deformation under pressure, which tends to lower the porosity of the powder bed. The other 
method used, so called out-of-die or zero-pressure measurement therefore describes the powder 
behavior more accurately. The reason of the curvature arise at high pressures is often considered 
to be a strain hardening (Gabaude et al., 1999). Sun and Grant (2001) explain the curve behavior 
in the last region with an elastic deformation of the powder, as already mentioned. This elastic 
deformation can even lead to a negative porosity and therefore to a value for relative density higher 
than 1. In addition, there is a mathematical reason for the curvature arise, which is valid for both in-
die and out-of-die measurements (Sun and Grant, 2001). A small difference in relative density (ρr) 
values do not cause a significant difference in the expression ln(1/(1-ρr)), except at very high 
relative density values. Thus the proportional difference becomes much higher when ρr is high. The 
value of the relative density is always influenced by measurement errors, i.e. determination of true 
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density, tablet weight, and tablet volume. In addition it has to be kept in mind that the punch and 
die are elastic and compressed as well during the compaction of the powder. Therefore, data 
points at relative density more than 0.95 should be used with caution, because they can cause 
deviations from linearity.  
 
Although Heckel plots are mostly used to characterize single materials, they can also be used to 
describe the behavior of powder mixtures. Ilkka and Paronen (1993) investigated some different 
binary mixtures. They found that all the mixtures behaved like intermediate materials between the 
bulk mixture components. Yet, no exact linear relationship in behavior between the mixtures and 
bulk components was seen. In most of the cases, one mixture component seemed to have more 
effect on the densification of the powder mixtures than the other.  
 
Physical interactions in binary powder mixtures can also be detected by the following equation (Eq. 
(3.6)) developed by Leuenberger (1980) for the parameter, which describes the compressibility γ: 
 
 
( ) BAmixture xx γγγ ⋅−+⋅= 1        (3.6) 
 
with x corresponding to the percentage of the component of the binary mixture for drugs and 
excipients, which have similar true densities. In the same publication the strength of the compact of 
the binary powder mixture described with the deformation hardness Pmax (at zero porosity) was 
estimated as follows: 
 
 xx
BAmixtureAB
PPP −⋅= 1maxmaxmax        (3.7) 
 
with Pmax A, Pmax B describing the compactibility of the powder A, B based on the following general 
equations for both powders: 
 
 )1(max crAA ePPA
σργ−
−=        (3.8) 
 
 )1(max crBB ePPB
σργ−
−=        (3.9) 
 
 )1( ))1((1maxmax, crBABA
xxxx
BA ePPP
σργγ ⋅−+⋅−−
−⋅=      (3.10) 
 
with ρr indicating the relative density and σc indicating the compression stress. 
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3.1.7 Modified Heckel equation 
 
For the description of the powder behavior under very low compression pressures, Kuentz and 
Leuenberger (1999) postulated a modified Heckel equation, which allows the description of the 
transition between the state of a powder and the state of a tablet. It considers that the pressure 
susceptibility (χp), which is defined as the decrease of porosity (ε) under pressure, can only be 
defined below a critical porosity (εc) or above the corresponding critical relative density (ρc), 
because a rigid structure exists there. Taking this into account, the following function was defined: 
 
cr
p
C
ρρ
χ
−
∝          (3.11) 
 
where χp is the pressure susceptibility, ρr is the relative density, ρc is the critical relative density and 
C is a constant. The new density versus pressure (σ) relationship can be described in the modified 
Heckel equation: 
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−
−
−−−=
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crcC ρ
ρρρρσ
1
1ln)1(1       (3.12) 
 
According to the constant K in the Heckel equation, the constant C in the modified Heckel equation 
is indicating plastic powder behavior with high values and brittle powder behavior with low values.  
 
 
3.1.8 Special cases 
 
3.1.8.1 Pellet compression 
 
The compression of pellets is a special case of powder compression. In the recent years a lot of 
work has been done on that special research field, obviously because pellet compaction has some 
advantages in the preparation of modern dosage forms. Oral controlled release multiple dosage 
forms are becoming more and more important due to their improved bioavailability and safety of 
drug release. After disintegration of the tablets in the stomach, pellets with a particle size below 2 
mm behave like liquids and have a short transit time through the stomach. The spreading of the 
multiparticulates across large sections of the intestine results in less variations in drug release. 
Pellets as multiple unit dosage forms are often filled into hard gelatine capsules. Less frequently 
they are compressed into tablets. Advantages of tablets compared to capsules comprise cost 
effectiveness and dividability (Wagner et al. 1999). In addition, the content uniformity of solid low-
dosage forms is a major challenge in the pharmaceutical industry. With the compaction of drug-
coated pellets, content uniformity can be reached quite easily (Martinez et al, 2001). 
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Pellets are a special form of granules, characterized by a very regular, round shape, a low porosity 
and a smooth surface (Leuenberger and Martin, 2002). Synonyms for pellets are spheres, cores 
and beads. 
In general, powder compression principles are valid for pellet compression. The special character 
of pellets (round shape, low porosity and smooth surface) though, is responsible for some special 
compression behavior.  
 
Some authors studied the compression behavior of pellets and it is possible to make statements 
about deformation behavior of pellets and the influence of various parameters like original pellet 
material, porosity, size, coating, fillers and cushioning substances.  
Johansson et al. (1995) found that generally, discrete pellets can clearly be distinguished within a 
compact although the separation distances between the pellets are very low. The size and 
appearance of the pellets in the compact are similar to the original characteristic of the pellets. 
Thus, pellets tend to keep their integrity when compacted and do not fragment into smaller units. 
Therefore, the dominating mechanism of compression seems to be deformation in combination 
with a densification. A deformation of a pellet during compression is probably caused by 
repositioning of the primary particles, which constitute the pellet (Johansson et al., 1995). An 
increased tensile strength with augmentation of compaction pressure and initial pellet porosity was 
explained by Nicklasson et al. (1999a) with an increased degree of deformation during compaction. 
The occurrence of extensive deformation of the pellets facilitates the development of intergranular 
bonding forces. 
 
The porosity of a tablet is generally independent on the porosity of the pellets before compaction. 
But increasing the pellet porosity increases the compressibility and compactibility of the pellets, i.e. 
the degree of deformation and densification of individual pellets can increase with pellet porosity 
(Nicklasson et al., 1999a). According to Johansson et al. (1995), Nicklasson et al. (1999a) and 
Martinez et al. (2001) the compression behavior of pellets is always rather plastic than brittle, 
fragmentation does not occur. Even with typical brittle pellet building substances like sugar 
(Martinez et al., 2001) or a 4 to 1 mixture of dicalcium phosphate dihydrate and microcrystalline 
cellulose (Nicklasson et al., 1999b). Nevertheless, Nicklasson et al. (1999a) found a difference in 
behavior of pellets derived from microcrystalline cellulose to the behavior of pellets derived from a 
4 to 1 mixture of dicalcium phosphate dihydrate and microcrystalline cellulose. The degree of 
compression and compaction was higher for the former pellets than for the latter. The cause for 
that behavior is probably the difference in the hardness or deformability between the primary 
particles of the two substances. It is therefore easier for ductile particles to change their relative 
positions than it is for particles of a hard, less deformable material.  
Johansson et al. (1998) studied the effect of pellet size on the compaction behavior. They found 
that the degree of pellet densification during compression was controlled only by the pressure 
applied while the degree of deformation was controlled by both, the applied pressure and the size 
of the pellets. The reason is probably that during uniaxial compression of an assembly of particles, 
Theoretical Section 
 19 
the force applied to the powder is transmitted through the powder bed at points of interparticulate 
contact. Increasing the size of the particles will reduce the number of force transmission points. 
Thus, the contact force at each interparticulate contact point will increase, which leads to increased 
pellet deformation.  
 
The comparison between the compaction behavior of pellets and the compaction behavior of more 
irregular granules with higher porosity by Johansson and Alderborn (2001) showed that more 
irregular granules are more compressible. Obviously, the degree of granule deformation occurring 
during compression depends on the combined effects of the intragranular porosity and the granule 
shape. A more irregular shape increases the bed voidage, which allows an increased degree of 
deformation to which the granules can undergo during compression.  
 
A further interesting point of research is the coating of pellets. On the one hand there are known 
drug pellets coated with a polymer film for protection or to influence the drug release. On the other 
hand there are cores layered with an active drug substance. For both kinds of pellets it is important 
to know if there is an influence of the coating on the behavior of the pellets under compression. 
Maganti and Celik (1994) found that coated pellets have better plastic properties than uncoated 
pellets of the same nature. An increase in the amount of coating applied caused a reduction in the 
yield pressure of the pellets. Tunon et al. (2003) also investigated the compression behavior of 
coated pellets and showed that the coated pellets behaved like the uncoated pellets. The coating 
did not significantly influence the compression behavior of the pellets. After deaggregation of the 
tablets the retrieved pellets were similar to the original pellets and there was no tendency for the 
polymer film to become convoluted. Therefore the film continued to coat the deformed pellets even 
after compaction, i.e. the coating is able to adapt to the densification and deformation of the pellets. 
Martinez et al. (2001) confirmed that statement. Pellet coating with a ductile polymer did not cause 
any changes in the compression characteristics of the uncoated pellets, moreover, the small value 
for the yield stress of the uncoated pellets, indicating plastic behavior could even be decreased by 
coating the pellets with the ductile polymer. 
 
Conclusively it can be stated that pellets under pressure show on the one hand deformation, i.e. a 
change in shape and on the other hand a densification, i.e. a decrease in volume. Compressibility 
and compactibility can be influenced by the porosity of the pellets and the material of the primary 
particles. Nevertheless, fragmentation of pellets under compaction could not be found. The coating 
of pellets does not significantly influence the compression/compaction behavior. 
 
 
3.1.8.2 Enzyme compression 
 
Proteins and polypeptides are getting more and more important in the field of new drugs. As a 
consequence it is necessary to gain information on the stability of these substances, mainly 
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regarding the application of pressure. Enzymes as a special group of proteins have an activity that 
can be measured and quantified. Investigation of pressure-induced effects on the activity of 
enzymes dissolved in water showed that denaturation occurred, but was mainly reversible when 
the stress was released (Teng and Groves, 1988). That fact suggested a possible influence of 
compaction pressure on enzymes in dry state and is therefore of interest in different research 
groups for the last few years.  
 
Teng and Groves (1988), Zarrintan et al. (1990), Wurster and Ternik (1994), Schulz et al. (1997) 
and Nürnberg and Scheler (2000) found that different enzymes investigated showed activity loss 
under compression. It was suspicious that between a compaction pressure of 100 and 250 MPa a 
sudden activity loss of 10 to 50% depending on the enzyme investigated was found. Consistently it 
was found that the apparent density of the compacts correlated with the enzyme activity. Thus, the 
sudden activity loss can be explained by a disappearance of voids in the compact and a 
consequent mechanical damage of the protein molecules. Volume reduction forces the molecule to 
change its shape, structural changes are necessary and cause a denaturation of the protein. 
Obviously this denaturation in dry state of the enzyme is irreversible. It is stated that the irreversible 
inactivation may involve the formation of incorrect enzyme conformations upon association or the 
loss of the ability of subunits to associate due to substantial structural changes probably because in 
solid state compression there is created a heterogeneous pressure distribution (Wurster and 
Ternik, 1994). The creation of new bonding within the enzyme molecule during compression is a 
further possible explanation (Schulz et al., 1997). These bonds could hinder the recreation of the 
native structure of the enzyme during dissolution.  
 
A further explanation for the induced activity loss is a possible heating during compression. 
Enzymes are known to be heat-labile. Although several authors mentioned that possibility of 
thermal inactivation there is no evidence on that statement. Teng and Groves (1988) and Zarrintan 
et al. (1990) could show that the tableting speed had no effect on the activity loss, though it could 
be expected, that heat development in the compact would be dependant on the compression 
speed. Schulz et al. (1997) compared the activity loss after compression at 14°C and room 
temperature and did not find significant differences. Nürnberg and Hamperl (1986) compared the 
influence of compaction pressure, temperature and shearing forces and found that the compaction 
pressure is mainly responsible for the activity loss of compacted enzymes. Selective heat 
development in the compact during compression is of course possible and denaturation by hot 
spots is imaginable, since Weichert and Schönert (1976) found very high temperatures at the 
fractured surface of particles, e.g. the maximum temperature in the fracture zone in glass was 
2927°C. 
 
The compression characteristics of enzyme powders can of course be determined. Nürnberg and 
Scheler (2000) found a plastic behavior of their enzyme powders investigated. Heinämäki (1991) at 
the contrary could show that the enzyme he investigated showed a brittle compression behavior. 
Therefore there is no general statement possible concerning the compression character of an 
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enzyme powder. The compression behavior of these powders is probably dependent on the origin 
and production of the powder product. The enzyme powders used for compression, i.e. solid 
enzymes, are rarely pure enzymes. Mostly they are produced by lyophilisation, which requires an 
addition of excipients.  
 
The influence of tableting excipients on the enzyme activity loss was also investigated. Graf et al. 
(1980) showed that microcrystalline cellulose caused a higher activity loss than dicalcium 
phosphate dihydrate. Unfortunately it is not stated if the enzyme powder used can be characterized 
with plastic or brittle compression behavior. Heinämäki (1991) stated that microcrystalline cellulose 
could have a negative influence on the enzyme activity because of its high compressibility. The big 
range of volume reduction causes friction during the compression process, which can be 
responsible for heat transformation and the creation of shearing forces. Yet, Heinämäki (1991) did 
not measure the activity loss to confirm his statement.  
 
Summarizing the actual standard of knowledge it could be proved that enzyme activity decreases 
under pressure, obviously depending on the apparent density of the tablets produced. A lot of 
possible explanations for that behavior exist, but yet no real proof of processes happening within 
the compact is given. A further investigation of influences of tableting excipients seems to be 
helpful to get more information for the description of the compression behavior of enzymes.  
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3.2 Percolation theory 
 
Percolation theory is used to explain certain regularities of critical phenomena in disordered 
systems. Disordered systems can be found anywhere in nature and thus, percolation theory has a 
broad field of application. It can be used for example to explain the fire propagation in forests as 
well as the gelation during egg boiling.  
The description of a system is based on its classification into an (infinite) number of subunits, which 
are in geometrical order. In addition, each subunit needs to have the possibility to assume two 
different properties of condition. With an increasing probability of the one or the other condition, the 
physical properties of the whole system do change. In the area of a certain, so-called critical 
probability sudden changes occur. Percolation theory is a tool to confirm and pre calculate these 
critical probabilities as well as the behavior of the physical properties of a system.  
 
Flory (1941) and Stockmayer (1943) were the first to use such concepts to describe polymers and 
gelation. The terminology of percolation is based on investigations on the flow of fluids through 
porous material by Broadbent and Hammersley (1957). The application of percolation theory in the 
field of pharmaceutical technology was introduced by Leuenberger in the late eighties 
(Leuenberger et al., 1987).  
 
The basic concepts of percolation theory are presented in the following, more detailed introductions 
are given by Stauffer and Aharony (1995) and Sahimi (1994). 
 
 
3.2.1 Principles of percolation theory 
 
Percolation theory can be applied on systems, which can be characterized as a lattice. A lattice 
consists of an infinite number of lattice sites arranged in a certain geometrical structure. One-, two- 
and three-dimensional lattices can be described (Fig. 3.6). 
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cubic lattice 
(three-dimensional) 
Bethe lattice 
(infinite dimensionality) 
 
one-dimensional lattice square lattice 
(two-dimensional) 
honeycomb lattice 
(two-dimensional) 
 
 
Fig. 3.6: Examples for different lattice types (Stauffer and Aharony, 1995, Sahimi, 1994). 
 
 
In the group of two-dimensional lattices there are for example the square lattice, the honeycomb 
lattice or the triangular lattice. In the three-dimensional space there are described the diamond 
lattice, the simple cubic lattice, the body centered and the face centered cubic lattice. In addition 
the Bethe lattice can be mentioned as a special case because its dimensionality is infinite.  
 
The sites of the lattice can either be occupied with the probability ps or remain unoccupied with the 
probability (1-ps) That randomly occupation is independent on the occupation condition of the 
neighboring sites. In the case of ps=1, every site is occupied and no empty spaces are remaining. 
Looking at one occupied site, a differentiation between direct and indirect neighbors is possible 
(Fig. 3.7). Direct or so-called nearest neighbors are sites, which share one face with the neighbor. 
Indirect or so-called next nearest neighbors though, touch on the edges.  
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square lattice cluster occupied sites 
direct neighbors indirect neighbors 
Fig. 3.7: Illustration of some principles of percolation theory (Stauffer and Aharony, 1995). 
 
 
An isolated group of directly neighboring occupied sites is termed cluster (Fig. 3.7). The number 
and properties of these clusters is the main topic of percolation theory.  
 
The type of percolation described so far is called site-percolation. The other known percolation type 
is the bond-percolation. With this kind of percolation every site of the lattice is occupied, i.e. the 
occupation probability ps is one. Bonding between these directly neighboring occupied sites is built 
with the bonding probability pb or bonding does not exist with the probability (1-pb). In the case of 
bond-percolation a group of occupied sites connected with bonds is called a cluster.  
 
The combination of these two types of percolation is termed site-bond-percolation. In the case of 
this site-bond-percolation the sites are occupied with the occupation probability ps and the building 
of bonds between two directly neighboring occupied sites results with the bonding probability pb. A 
cluster is therefore a group of directly neighboring occupied sites connected with bonds.  
 
If the occupation of the sites is not randomized but in dependence on the occupation of the 
neighbors, the percolation is correlated. The neighboring sites of occupied sites are either 
preferably occupied or avoided.  
 
A directed system consists of a lattice in which the bonding has a special direction. This type of 
percolation is therefore called directed percolation. 
 
In the special case of lack of lattice type definition where the sites are distributed randomly, the 
percolation type is called continuum percolation.  
 
Fig. 3.8 gives an overview of the different types of percolation described above.  
Theoretical Section 
 25 
 
 
 
site bond site-bond directed continuum 
 
Fig. 3.8: Schematic overview of different types of percolation. 
 
 
3.2.2 Percolation threshold 
 
As already mentioned, percolation theory describes the number and properties of clusters. 
Depending on the occupation probability and the bonding probability, respectively clusters of 
different sizes and numbers can appear in a lattice. With a small occupation probability ps and 
bonding probability pb, respectively a lot of small clusters exist. These clusters are limited in their 
size. With an increasing probability ps and pb, respectively the size of the clusters also increases. At 
a certain probability pcs and pcb, respectively there exists for the first time a cluster which penetrates 
the lattice in the whole dimension describing an “infinite” cluster (see the two-dimensional case of a 
square lattice in Fig. 3.9).  
 
 
 
 
Fig. 3.9: Square lattice with an occupation probability ps below the percolation threshold with 
two finite clusters (left side) and an occupation probability ps above the percolation 
threshold with an infinite cluster percolating the system (right side). (Stauffer and 
Aharony, 1995). 
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This critical concentration is called percolation threshold. The cluster at the percolation threshold is 
called infinite cluster and if the probability ps and pb, respectively further increase, the infinite cluster 
also increases while the number and size of the finite clusters decrease. 
 
The percolation threshold is dependent on the one hand on the type of percolation (site or bond) 
and on the other hand on the type of lattice. Generally, the percolation thresholds of three-
dimensional lattices are always lower than percolation thresholds of two-dimensional lattices and 
the percolation thresholds for bond-percolation are lower than the one for site-percolation. The 
reason is obvious since in both cases, i.e. three-dimensional lattice and bond-percolation, 
respectively, there are more direct neighbors to build an infinite cluster.  
 
 
3.2.3 Application of percolation theory in powder technology 
 
The application of percolation theory in powder technology enables a new perspective on various 
problems. Leuenberger (1999) summarizes the progress in that field.  
 
In the field of powder compression of binary mixtures the following model of percolation theory is 
applied.  
In a binary mixture consisting of substance A and B, the lattice is formed by particles of type A or 
type B. As long as substance A builds a cluster in the lattice, i.e. many particles of substance A are 
direct neighbors it can be stated that substance A dominates the behavior of the system. With an 
increasing amount of substance B, clusters consisting of substance A get destroyed. More and 
more sites in the lattice get occupied by substance B. The system is penetrated by clusters of 
substance A as well as clusters of substance B. Thus, a certain point can be defined where the 
system domination of substance A is replaced by a system domination of substance B, i.e. a phase 
inversion takes place. This critical concentration is therefore called percolation threshold. The 
geometrical packaging is a function of the particle size, the particle size distribution and the shape 
of the particles. Different tablet properties of binary powder compressions have been investigated, 
e.g. intrinsic dissolution rate (Holman and Leuenberger, 1990), disintegration time (Leuenberger et 
al., 1987), Brinell hardness (Leuenberger et al., 1989; Holman and Leuenberger, 1990), tap density 
(Holman and Leuenberger, 1990). Percolation thresholds have been proved for each of these 
tablet properties with a sudden change of the tablet behavior.  
For the development of formulations of solid dosage forms it is therefore necessary to avoid these 
critical mixture ratios to guarantee sufficient robustness of the formulation.  
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3.3 β-Galactosidase 
 
β-Galactosidase, also called lactase (EC 3.2.1.23) is widely distributed in nature. This is not 
surprising being aware of the fact that oligo- or polysaccharides containing D-galactose joined 
through a β-glycosidic bond occur in most if not all organisms (Wallenfells and Weil, 1972). Thus, it 
is obvious that the corresponding glycosidases are as widely distributed as their substrates. This 
universal occurrence coupled with the simple enzymatic assay and the availability of numerous 
substrates made β-galactosidase one of the most widely studied glycosidases. Moreover β-
galactosidase from Escherichia coli is of great interest regarding structure analysis due to its very 
big molecule weight (518 kDa). Molecule size and thus the behavior of the enzyme molecule is 
strongly varying from one organism source to the other, though. The great number of organisms 
containing β-galactosidase makes it sometimes difficult to find detailed information on a β-
galactosidase from a special source.  
 
The β-galactosidase used in this work occurred from Aspergillus oryzae. It was chosen as a model 
enzyme because of its molecular weight of about 105 kDa (Tanaka et al., 1975), which 
corresponds to an average molecular weight for enzymes. Moreover, the enzyme activity test is 
simple to handle and reliable. β-Galactosidase from Aspergillus oryzae is very stable and as a 
further important aspect the used enzyme preparation is economic, which was of importance 
because of the relatively big amounts used for tablet preparation.  
 
The following chapters give an overview of the character and properties of β-galactosidase in 
general as well as β-galactosidase from Aspergillus oryzae. 
 
 
3.3.1 Source and application 
 
β-Galactosidase can be found in several plants, animals, bacteria, yeast and moulds. In plants, 
high enzymatic activities are found in seeds and leaves where the enzyme is probably related to 
the catabolism of galactolipids, such as β-D-galactosyl diacylglycerol, which are universally 
distributed in plants and algae (Wallenfels and Weil, 1972). Microorganisms do also produce β-
galactosidase, which is used for technological use as it is economic and the availability is good. 
Normally the enzyme remains in the endproduct and therefore it is important that the enzyme 
sources are compatible with nutrition regulations if the technological process is used for nutritional 
products. Commonly used microorganisms for that purpose are yeasts like Saccharomyces lactis, 
Saccharomyces fragilis and Candida pseudotropicalis, moulds like Aspergillus niger, Aspergillus 
oryzae and Mucor meihei and bacteria like Bacillus stearothermophilus, Streptococcus lactis and 
Lactobacillus bulgaricus (Stellmach, 1988). The widespread occurrence of β-galactosidase in 
mammalian organs is probably related to the multiple physiological functions of the enzyme. The 
Theoretical Section 
 28  
role for intestinal β-galactosidase for the hydrolysis and consequently for the absorption of dietary 
lactose is well known (Wallenfels and Weil, 1972). About 70% of the adult world population is not 
able to digest lactose because of lack of the enzyme β-galactosidase in the small intestine. 
Absorption of milk and milk products causes symptoms like diarrhoea, convulsions and flatulence 
(Stellmach, 1988). Pharmaceutical application of β-galactosidase for the decomposition of lactose 
into glucose and galactose to avoid these symptoms is therefore necessary.  
 
 
3.3.2 Structure 
 
Structure analysis of the enzyme β-galactosidase was mostly done from the source of Escherichia 
coli. The molecule from this source was found to be a tetramer with a molecular weight of 518 kDa, 
its shape can be described as an oblate ellipsoid. The length and height of the molecule were 
calculated to be 150 and 50Å, respectively (Wallenfels and Weil, 1972). Data on the properties of 
β-galactosidase from other origins are very rare. Nevertheless, the small number of information 
shows that there are big differences between the various origins. Data from Aeromonas formicans 
and Aerobacter cloacae appear to have similar properties to that of E. coli, while the enzyme from 
Staphyolcoccus aureus has a molecular weight of 50 kDa and consists of one polypeptide chain. 
The molecular weights of the enzymes from Bacillus megaterium and Sporobolomyces singularis 
were found to be in the range of 140-150 kDa (Wallenfels and Weil, 1972). 
The molecular weight of β-galactosidase from Aspergillus oryzae was found to be 105 kDa (Tanaka 
et al., 1975). This was confirmed by Akasaki et al. (1976), who also asserted that β-galactosidase 
from Aspergillus oryzae has not subunit structure.  
 
Thus, the size of the enzyme from Aspergillus oryzae corresponds more or less the size of one 
monomer from E. coli. Based on that fact and the lack of subunit structure, it is supposed that β-
galactosidase from Aspergillus oryzae has similar structure to that of the monomer of the enzyme 
from E. coli.  
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Fig. 3.10: Structure of a monomer of β-galactosidase from E. coli. D1-D5 indicate the five 
domains, a indicates the active site (Juers et al., 2000). 
 
 
The structure of β-galactosidase from E. coli was investigated by Juers et al. (2000). The monomer 
(116 kDa) is formed of five structural domains (Fig. 3.10). The active site is located at the C-
terminal end of the central core of domain 3 and includes also portions of loops from domain 1, 
domain 2 and domain 5 of the monomer. The presence of magnesium ions in the active site 
suggests the enzyme being a metal enzyme.  
 
The amino acid composition of β-galactosidase from Aspergillus oryzae was analyzed by Tanaka 
et al. (1975) and is shown in Tab. 3.1. 
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Tab. 3.1: Amino acid composition of β-galactosidase from Aspergillus oryzae (Tanaka et al., 
1975). 
 
Amino acid Amino acid Weight %
(M/105 g Protein)
Alanine 58.1 5.2
Arginine 23.3 4.1
Aspartic acid 89.2 11.9
Cysteine 2.1 0.3
Glutamic acid 70.0 10.3
Glycine 82.2 6.2
Histidine 12.8 2.0
Isoleucine 29.8 3.9
Leucine 69.7 9.1
Lysine 34.5 5.0
Methionine 7.3 1.1
Phenylalanine 39.9 6.6
Proline 60.6 7.0
Serine 60.9 6.4
Threonine 53.9 6.4
Tryptophan 10.5 2.1
Tyrosine 42.6 7.7
Valine 41.3 4.8  
 
 
3.3.3 Reaction 
 
Investigations on the kinetics of the β-galactosidase catalysis proposed a Michaelis-Menten kinetic 
with a three-step mechanism: 
 
211
32 PPEPSEESSE kkKS ++→+′→ →←+     (3.13) 
 
It includes rapid binding of the substrate S to yield the Michaelis complex ES, formation of the 
intermediary complex ES´ with simultaneous elimination of the aglyconic leaving group P1 and 
hydrolysis of the ES´ complex to yield free galactose P2 and the Enzyme E (Wallenfels and Weil, 
1972). 
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lactose 
glucose 
galactose 
 
 
Fig. 3.11: Reaction mechanism of β-galactosidase. 
 
 
The reaction mechanism (Fig. 3.11) catalyzed by the enzyme is a β-galactosidic cleavage of di- 
and oligosaccharides, respectively from the galactose side. Glycoside cleavage results between 
the anomeric C-atom of the galactose part and the ether-oxygen atom. The galactose part of the 
galactose-enzyme complex is hydrolysed releasing the enzyme (Stellmach, 1988). 
 
 
3.3.4 Properties and stability 
 
According to the investigations of Tanaka et al. (1975) the pH optimum of β-galactosidase from 
Aspergillus oryzae is at 4.5. During storage the enzyme is stable in a pH range of 4.0 to 9.0, i.e. the 
activity does not decrease. Influence of temperature on the enzyme activity and stability is also 
obvious. For the incubation temperature maximum activity is observed at 46°C. At pH 4.5 the 
enzyme is stable at 40°C for 10 minutes.  
 
The hydrolysis of the substrate can be inhibited by Cu2+ and Ag+ at a concentration of 10-2 M and 
Hg+ at a concentration of 10-4 M. No influence of other metal ions is known. A complete destruction 
of the enzyme activity is shown by N-bromosuccinimide and sodium laurylsulfate. EDTA, 
mercaptoethanol, hydrogen peroxide, sodium thiosulfate, cysteine and ascorbic acid, though have 
no effect on the enzyme activity. Maltose, galactose and lactose at concentrations of 10-1 M can 
slightly inhibit the hydrolysis of the substrate while other sugars do not show any effect at the same 
concentration (Tanaka et al., 1975).  
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For the investigation of the enzyme activity different substrates can be employed beside the natural 
substrate lactose. Some requirements are essential according to Wallenfels and Weil (1972). The 
substrate needs to have a D-pyranoside ring, substitution at C-2, C-3, C-4 and C-6 by groups that 
are bigger than the hydroxyl group prevents binding of the galactoside to the active site. β-
galactosidic linkage is specific. In addition, glycosidic oxygen of β-D-galactosides is essential, i.e. 
sulfur replacement clearly decreased the enzymatic hydrolysis. 
 
Often used substrates for the hydrolysis of β-galactosidase are o-nitrophenyl-β-D-galactosides 
(ONPG). Akasaki et al. (1976) found that the activity measured with ONPG was almost five times 
higher than the activity measured with lactose in the same concentration. The Michaelis constant 
(Km) value for ONPG is in the range of 10-4 M (Wallenfels and Weil, 1972 and Tanaka et al., 1975). 
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4 Materials and Methods 
 
4.1 Substance characterization 
 
For the characterization of the enzyme powder as well as the various excipients basic data 
acquisition was done with standardized methods for powder characterization.  
 
True density was measured with a Beckman® Air Comparison Pycnometer Model 930 (Beckman 
Instruments, Fullerton, USA), determination of particle size was done with a laser diffractometer 
Malvern® Mastersizer X (MSX 6142, Malvern Instruments, Worcestershire, UK) and bulk and 
tapped densities were characterized according to European Pharmacopoeia 3 (1997). 
 
 
4.1.1 β-Galactosidase 
 
The enzyme preparation used for all experiments is an enzyme powder from Aspergillus oryzae 
(Fluka Chemie GmbH, Buchs, Switzerland). This yellow powder is not a pure enzyme because 
solid enzyme preparations are normally gained by lyophilisation. Thus, buffer salts and other 
excipients can be found in the powder preparation depending on the production process. The exact 
amount of protein in the preparation is declared to be 40%, accompanied by 60% of dextrine.  
Data for true density, (relative) poured and (relative) tapped density, respectively and for the mean 
particle size of the β-galactosidase preparation from Aspergillus oryzae are shown in Tab. 4.1. 
 
 
Tab. 4.1: Characterization of β-galactosidase powder. 
 
Substance Densities Mean 
True Poured ρ p Tapped ρ t particle 
(g/ml) (g/ml) (rel) (g/ml) (rel) size (µm)
β-Galactosidase powder 1.42 0.714 0.503 0.851 0.599 60.0
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4.1.2 Excipients 
 
The following excipients were used for powder compression as well as for granulation: 
 
 Microcrystalline cellulose (MCC) 
 (Avicel® PH 102, FMC, Philadelphia, USA) 
 
 Dicalcium phosphate dihydrate (DCP) 
 (Emcompress®, Edward Mendell, New York, USA) 
 
 
The used pellet cores were the following: 
 
 Microcrystalline cellulose pellets 
 (Cellets®, Pharmatrans Sanaq AG, Basel, Switzerland) 
 
 Sugar pellets 
 (Suglets®, NP Pharm S. A. S., Bazainville, France) 
The sugar pellets contain not more than 92% of sucrose, the remainder consists of maize 
starch. 
 
 
The values for true density, (relative) poured and (relative) tapped density, respectively and for the 
mean particle size of the excipients mentioned above are shown in Tab. 4.2. 
 
 
Tab. 4.2: Characterization of excipients. 
 
Substances Densities Mean 
True Poured ρ p Tapped ρ t particle 
(g/ml) (g/ml) (rel) (g/ml) (rel) size (µm)
Microcrystalline cellulose 1.55 0.325 0.210 0.403 0.260 162.8
Dicalcium phosphate 2.38 0.926 0.389 1.042 0.438 187.3
Microcryst. cellul. pellets 1.37 0.831 0.607 476.9
Sugar pellets 1.56 0.839 0.537 456.1
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In addition, a buffer solution was used for all enzyme powder solutions. The citrate phosphate 
buffer of pH 4.5 consisted of 89.0 g disodium hydrogen phosphate dihydrate (Merck AG, Dietikon, 
Switzerland) and 62.0 g citric acid (Hänseler AG, Herisau, Switzerland) ad 5 l of double distilled 
water. 
 
 
4.2 Influences on β-galactosidase activity 
 
Enzymes are known to be sensitive on different influences. Thus, it was important to test if 
temperature and the number of excipients used for several studies could influence the activity of 
the enzyme powder β-galactosidase. 
 
 
4.2.1 Temperature 
 
The influence of different temperatures on the dry enzyme powder was investigated. The dry 
powder was exposed to room temperature, 30, 40, 50, 60, 70 and 80°C for 10 min, i.e. the duration 
of a compaction process. After this exposition the powder portions were dissolved in buffer solution 
at room temperature and the enzyme activity was detected and compared to a reference (see 
chapter 4.7.1).  
 
In a second test, the influence of different temperatures on the dissolved enzyme powder was 
investigated. Solutions of enzyme powder in citrate phosphate buffer (0.015 mg/ml) were prepared 
and exposed to 30, 40, 50, 60, 70 and 80°C for 30 min. After cooling to room temperature, the 
enzyme activity of the solutions was detected and compared to a reference (see chapter 4.7.1).  
 
 
4.2.2 Excipients 
 
The influence of various excipients, which have contact with the enzyme powder during powder 
compression, granulation and pellet coating, respectively was investigated. Thus, solutions with 
10% β-galactosidase powder and 90% of microcrystalline cellulose, dicalcium phosphate dihydrate, 
sucrose and maize starch, respectively in citrate phosphate buffer were prepared and the enzyme 
activity was detected and compared to a reference (see chapter 4.7.1). In addition, a solution of 
hydroxy propyl methylcellulose, also called HPMC (Pharmacoat® 603, Novartis Pharma AG, Basel, 
Switzerland) and β-galactosidase powder, 5% and 10% respectively was prepared and the enzyme 
activity was detected and compared to a reference as well (see chapter 4.7.1). Hydroxy propyl 
methylcellulose, which was used for the pellet coating, was also dissolved in buffer solution without 
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the addition of enzyme powder to detect possible influences of the polymer on the absorption in the 
enzyme assay.  
 
 
4.3 Powder mixtures 
 
Powder mixtures of β-galactosidase powder and microcrystalline cellulose as well as β-
galactosidase powder and dicalcium phosphate dihydrate were prepared for compression. These 
binary mixtures with the following amounts of β-galactosidase: 1, 10, 20, 30, 40, 50, 60, 70, 80, 
90% (w/w), were mixed in a blender (Turbula® T2C, W. Bachofen AG, Basel, Switzerland) for 5 
minutes. 
 
 
4.4 Granulation 
 
The granulates were produced with an Aeromatic Strea fluid bed spray granulator (Aeromatic AG, 
Bubendorf, Switzerland). The acrylic glass granulation cylinder was limited on the bottom by a 
perforated base with a sieve insert and on the top by four filter bags. The filter bags were blown out 
alternatively every 15 seconds with compressed air. Addition of the binding agent solution resulted 
with a peristaltic pump (Petro Gas Ausrüstungen, Berlin, Germany) over a top spray binary nozzle 
positioned 28 cm above the perforated base.  
 
The binding agent solution consisted of the binding agent, which was HPMC in a concentration of 
5% in double distilled water according to some pre trials. In addition, there was β-galactosidase 
powder in a concentration of 10% dissolved in this solution. To ensure the stability of the enzyme 
powder, the solution needed to have a pH value of 4.5, which required the presence of the 
appropriate amount of buffer salts.  
 
It was the aim of the granulation to layer powder particles with β-galactosidase. The powder 
particles were microcrystalline cellulose as a model substance for plastic behavior and dicalcium 
phosphate dihydrate as a model substance for brittle behavior, respectively. Layering of powder 
particles results cogently in an agglomeration of the small particles to granules. Nevertheless, the 
agglomeration was not the important part of these trials. The layering of the powder particles was 
necessary to be able to compare on the one hand the behavior of the mixtures of β-galactosidase 
powder and powder excipient and on the other hand the behavior of layered, regular shaped pellets 
to the irregular shaped powder excipients layered with β-galactosidase. 
 
For that reason the amount of layering substance was calculated in the same way as for pellet 
layering (see chapter 4.5). The amount of binding agent solution sprayed on the powder particles 
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was calculated for a theoretical l-value = 2. The l-value indicates the thickness of the film coating 
(see chapter 4.5). 
 
According to the different values for true density and particle sizes the amount of binding agent 
solution sprayed on 100 g of powder was different for the same l-value. 100 g of microcrystalline 
cellulose was sprayed with an amount of 271.2 g binding agent solution, whereas 100 g of 
dicalcium phosphate dihydrate was sprayed with an amount of 156.7 g binding agent solution.  
 
The process parameters for both powder excipients were the same (Tab. 4.3). 
 
 
Tab. 4.3: Process parameters for granulation. 
 
Spray pressure (bar) Spray rate (g/min) Nozzle (mm) Drying temperature (°C) Outlet temperature (°C)
1 2.3 1.1 32 25
 
 
 
Granulate characterization methods were the same as described in chapter 4.1 for powders. In 
addition, scanning electron microscopy pictures were taken to characterize the granulates.  
 
 
4.5 Pellet coating 
 
Microcrystalline cellulose pellets with a plastic behavior of the primary particles as well as sugar 
pellets with a brittle behavior of the primary particles were coated with β-galactosidase binding 
agent solution (see chapter 4.4).  
 
The amount of film-forming agent was calculated according to Eq. (4.1): 
 
DCA of amount layering=⋅
m
lS        (4.1) 
 
where DCA is the dry coating agent in g per 100 g cores and per cent, respectively, S is the 
surface of the core, i.e. pellet in mm2, m is the mass of one pellet in mg and l is the thickness of the 
film coating in mg DCA per cm2 surface. The amount of binding agent solution sprayed on the 
pellets was calculated for a theoretical l-value = 5. The surface of the pellets was calculated using 
Eq. (4.2). 
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2DS ⋅= π          (4.2) 
 
where D is the diameter of the pellet, i.e. the mean particle size in mm.  
 
Microcrystalline cellulose pellets were coated in a Mini-Glatt fluid bed spray granulator with Wurster 
insert (Glatt® GmbH, Binzen, Germany). The process parameters are shown in Tab. 4.4. 
 
 
Tab. 4.4: Process parameters for the coating of microcrystalline cellulose pellets.  
 
Spray pressure (bar) Spray rate (g/min) Nozzle (mm) Drying temperature (°C) Bulk temperature (°C)
2 2.6 0.5 50 34
 
 
 
Due to the small nozzle it was necessary to dilute the binding agent solution with buffer solution in 
a 1:1 ratio. 100 g of microcrystalline cellulose pellets were sprayed with an amount of 431.0 g 
diluted binding agent solution. The calculated value of 565.5 g binding agent solution (l-value = 5) 
could not be attained because the pellets started to glue up and fluidizing was no longer possible.  
 
The coating of sugar pellets was not possible in the Mini-Glatt fluid bed spray granulator because 
the various cores were too heavy due to their true density. For that reason the sugar pellets were 
coated in an Aeromatic Strea fluid bed spray granulator (Aeromatic AG, Bubendorf, Switzerland), 
which was also used for granulation (see chapter 4.4). The process parameters are shown in Tab. 
4.5. 
 
 
Tab. 4.5: Process parameters for the coating of sugar pellets. 
 
Spray pressure (bar) Spray rate (g/min) Nozzle (mm) Drying temperature (°C) Outlet temperature (°C)
1 2.6 1.1 52 32
 
 
 
100 g of sugar pellets were sprayed with an amount of 204.3 g binding agent solution. 
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In both cases the effective l-value was calculated (Eq. (4.3)). 
 
eff
theor
theoreff l
m
lm
=
∆
⋅∆         (4.3) 
 
where ∆mtheor is the sum of all non-volatile substances per 100 g pellets in g, ∆meff is the mass 
growth after coating of 100 g pellets in g, ltheor is the theoretically calculated l-value and leff is the 
effective l-value.  
 
Characterization methods for the coated pellets were the same as described in chapter 4.1. In 
addition, scanning electron microscopy pictures were taken to characterize the pellets and the 
coating films.  
 
 
4.6 Tablet compaction 
 
Tablets of bulk β-galactosidase powder, bulk excipients, powder mixtures, granulates and pellets 
were compressed on the Zwick® 1478 Universal Testing Instrument (Zwick GmbH, Ulm, Germany). 
An 8 mm-diameter punch was used to form round flat tablets of portions of 100±0.5 mg substance.  
 
Compaction forces of 2, 5, 7, 10, 15, 20, 40 and 60 kN (corresponding 40, 100, 140, 199, 298, 398, 
796 and 1194 MPa) were applied except for microcrystalline cellulose pellets where formation of a 
tablet was not possible below a compaction force of 5kN. The compaction force of 2kN was hence 
replaced by 6kN (120 MPa).  
The compression and decompression speed was 0.5 cm/min with a dwell time of 5 s at maximum 
pressure, the ejection speed was 5 cm/min. 
 
Fig. 4.1 shows typical compression profiles for the applied compaction forces.  
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Fig. 4.1: Typical compression profile for compaction forces of 5, 7, 10, 15, 20, 40 and 60 kN. 
 
 
For each system and compaction force five tablets were compressed, because the standard error 
of the average value does not significantly differ between a number of five samples and a higher 
number of samples. The standard error of the average value xs  is defined as shown in Eq. (4.4) 
(Lorenz, 1996). 
 
 
n
ssx =          (4.4) 
 
where s is the standard error of the samples and n is the number of the samples.  
A plot of the standard error of the average value against the sample number shows that the curve 
flattens after a sample number of five (Fig. 4.2).  
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Fig. 4.2: Plot of the standard error of average value against the sample number.  
 
 
From the compression process only out of die data were generated.  
 
Tablet thickness was measured out-of-die after compaction with a thickness gauge (Digitcal, Tesa 
S.A., Renens, Switzerland) and after a storage time of 24h at 45% relative humidity in a desiccator 
containing calcium sulfate (Drierite®, Fluka Chemie GmbH, Buchs, Switzerland).  
 
In addition, scanning electron microscopy pictures were taken from the compacts from pellets to 
characterize the behavior of the pellets under pressure.   
 
 
4.7 Analytical assays 
 
For the characterization of β-galactosidase powder, investigation of influences of temperature and 
excipients, characterization of the granulates and coated pellets and the studies on compression 
behavior of the enzyme the enzymatic activity was detected. In addition, instead of a determination 
of content of β-galactosidase in the granulates and pellets a determination of the amount of protein 
was accomplished. β-Galactosidase powder of course was also characterized by determination of 
the protein content.  
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4.7.1 Enzyme assay 
 
The enzyme activity was detected with the synthetic substrate o-nitrophenyl-β-D-galactopyranosid, 
called ONPG (Fluka Chemie GmbH, Buchs, Switzerland). ONPG is decomposed into o-nitrophenol 
(ONP) and galactose by β-galactosidase. ONP is colorless in acidic medium but yellow colored in 
alkaline medium. Thus, the concentration of ONP can be detected spectrophotometrically at a 
wavelength of 420 nm.  
 
The enzyme activity test was accomplished after extract chemie, modified by Amano (Stellmach, 
1988), adapted to the use on a microplate reader spectrophotometer (Versamax-Tunable-
Microplate-reader B02553, Molecular Devices Sunnyvale, USA). Hydrolysis of the synthetic 
substrate ONPG was used as a measure of the enzyme activity. The reaction mixture contained 
175 µl of ONPG solution (5.7mM in citrate phosphate buffer, pH 4.5) and 25 µl of enzyme in buffer 
for the verum wells (n = 3) and 25 µl of buffer solution for the control wells (n = 3), respectively. 
After incubation for 10 min at 30°C, the reaction was stopped by adding 50 µl of 1M Na2CO3 (Fluka 
Chemie GmbH, Buchs, Switzerland). Then the absorbance of the yellow colored product o-
nitrophenol (ONP) was measured at 420 nm. Absorbance value of the control was subtracted from 
the absorbance value of the enzyme solution and the activity Ac (U/mg) was calculated as shown 
in Eq. (4.5). 
 
wE
A
Ac
⋅⋅
⋅
=
1045.4
25.0420         (4.5) 
 
where A420 is the absorbance at 420 nm, 0.25 is the total volume of the reagents in ml, 4.45 is the 
absorbance of 1 µmol ONP per ml at 420 nm, 10 is the reaction time in min and Ew is the initial 
weight of the enzyme in mg/0.025 ml of solution used. One β-galactosidase unit corresponds the 
amount of enzyme, which produces 1 µmol of o-nitrophenol per minute under the presented 
experimental conditions.  
 
For the preparation of the enzyme solution enzyme powder as well as tablets, granulates and 
pellets were dissolved in buffer solution on the magnetic stirrer. The solution was then filtered and 
diluted as necessary to obtain a concentration of approximately 0.01 mg/ml. For the reference 
solution bulk β-galactosidase powder was dissolved and diluted in buffer solution to obtain the 
same concentration as for the enzyme solution. The absolute activity values measured in U/mg 
were converted into relative activity values assuming the absolute value of the reference being 
100%.  
 
The use of 96-well microplates (Plaque type B, non-sterile, Semadeni AG, Ostermundigen, 
Switzerland) allowed the measurement of 10 tablets, i.e. 2 batches or 10 other systems and five 
Materials and Methods 
 43 
references and their controls at the same time. The relative activity values referred to the 
references on the same plate and thus with the very same assay conditions.  
 
 
4.7.2 Protein assay 
 
The protein determination in β-galactosidase powder, granulates and pellets was accomplished 
after Lowry et al. (1951), modified by Peterson (1977) as it was proposed by Tanaka et al. (1975) 
and Akasaki et al. (1976) with bovine serum albumin (Sigma-Aldrich Laborchemikalien GmbH, 
Buchs, Switzerland) as a standard.  
 
Lowry protein assay is based on a complexation of copper with protein under alkaline conditions. 
Addition of the Folin phenol reagent leads to a protein binding. The bound reagent is slowly 
reduced and changes color from yellow to blue.  
 
For the determination of the protein content five standard solutions with a protein concentration of 
5, 10, 20, 30 and 40 µg protein/ml were prepared to get a standard curve for the calculation of the 
protein content of the samples. Sample solutions were prepared with a protein content of 
approximately 20 µg/ml and a blank solution was also prepared for control. Standards, blanks and 
samples were prepared in triplicate and treated equally. To exclude interaction of substances in the 
protein solution the protein needed to be precipitated in a first step. To 1 ml of protein solution in a 
microtube (1.5 ml, Treff AG, Degersheim, Switzerland) 100 µl of 0.3% sodium deoxycholate 
solution (Sigma-Aldrich Laborchemikalien GmbH, Buchs, Switzerland) were added, mixed and 
incubated at room temperature for 10 min. Then 100 µl of 72% trichloroacetic acid were added and 
mixed again. After centrifugation for 30 min at 3000x g (Centrifuge 5415C, Vaudaux-Eppendorf AG, 
Schönenbuch, Switzerland), the tubes were placed upside-down in a rack for a few minutes. 
Remaining fluid on the rim of the tubes was removed. The pellets in the tubes were dissolved in 
400 µl double distilled water and 400 µl of reagent A (mixture of equal parts of copper-tartrate-
carbonate solution (0.1% copper sulfate pentahydrate (Fluka Chemie GmbH, Buchs, Switzerland), 
0.2% tartaric acid solution (dipotassium salt, Sigma-Aldrich Laborchemikalien GmbH, Buchs, 
Switzerland), 10% sodium carbonate (Fluka Chemie GmbH, Buchs, Switzerland)), 0.8 N sodium 
hydroxide (Fluka Chemie GmbH, Buchs, Switzerland), 10% sodium dodecylsulfate (Sigma-Aldrich 
Laborchemikalien GmbH, Buchs, Switzerland) and double distilled water) were added. After 
incubation at room temperature for 10 min 200 µl of reagent B (solution of 1 volume Folin-Ciocalteu 
phenol reagent (Sigma-Aldrich Laborchemikalien GmbH, Buchs, Switzerland) and 5 volumes of 
double distilled water) were added and immediate vortexing was necessary. After incubation at 
40°C for 30 min the protein solutions were filled in a 96-well microplate (n = 3) and 5 µl of ethanol 
were added to each well to prevent bubble formation. The absorbance of the blue solutions was 
detected at 750 nm.  
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4.8 Data interpretation 
 
The mathematical and graphical data interpretation was done with Microsoft Excel (Office 2000, 
Microsoft Corporation, Redmond, USA) and a statistics program (SYSTAT Version 7.0 for 
Windows®, SYSTAT Inc., Evanston, IL, USA). 
 
 
4.8.1 Non-linear regression 
 
The percolation threshold of the various systems was determined by dividing the data in the graph, 
i.e. the curve into two straight lines. Using non-linear regression, the data were fitted to Eq. (4.6). 
 
)()( 2211 bxmBbxmAy +⋅++⋅=       (4.6) 
 
where x and y are properties of the system, m (respectively m1, m2) is the slope, b (respectively b1, 
b2) is the intercept and A and B are constants. The data points around the critical value, i.e. the 
percolation threshold shown as a bend in the curve, were attributed alternatively to the first section 
or to the second section. The final attribution was made considering the correlation coefficient R2 
for the overall fit.  
 
 
4.8.2 Correlation 
 
Several curves with different properties have been correlated using Eq. (4.7). 
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where r is the correlation coefficient, n is the number of data, xi and yi are the various data points of 
the two correlated properties, x  and y  are the average values of the properties and σx and σy 
are the standard deviations of the properties.  
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5 Results and Discussion 
 
 
5.1 Influences on β-galactosidase activity 
 
The influence of temperature and different excipients on the enzyme activity was tested. These 
investigations led to necessary information concerning the stability of the enzyme powder. This 
knowledge is important for the characterization of the enzyme powder and thus for the further 
treatment of the enzyme powder preparation in the different studies.  
 
 
5.1.1 Temperature 
 
The measurement of the influence of the exposure of dry enzyme powder to different temperatures 
for the time of a compaction process showed a clear activity increase up to an exposure 
temperature of 80°C (Fig. 5.1). 
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Fig. 5.1: Temperature stability test on dry enzyme powder (n = 3). Error bars: ± 1 standard 
deviation.  
 
 
The activity increase between 30° and 70°C is statistically significant (ϕ = 95%) compared to the 
reference at room temperature. The activity increase at 80°C though does not significantly differ 
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from the reference at room temperature. None of the probes investigated showed an activity 
decrease.  
 
The activity increase between room temperature and 80°C is not astonishing since optimum 
stability temperature of the enzyme β-galactosidase from moulds is expected at 45-50°C. 
Moreover, the optimum efficacy of β-galactosidases from moulds lies between 50° and 60°C 
(Stellmach, 1988).  
For the use of dry enzyme powder for tablet compaction, problems are not expected to arise from 
temperature development in die. Temperature arise over 80°C during compression is not probable 
(Travers and Merriman, 1970; Wurster and Creekmore, 1986). Hence, possible activity loss during 
compression may not derive from a warming in die.  
 
Investigation of temperature stability on enzyme solutions showed a different behavior from the 
temperature stability test on dry enzyme powder (Fig. 5.2). 
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Fig. 5.2: Temperature stability test on enzyme solutions (n = 3). Error bars: ± 1 standard 
deviation.  
 
 
The solutions stressed at different temperatures showed activity decrease compared to the 
reference at room temperature. Between 60° and 80°C there was no activity detection possible. 
The solutions at 30° and 40°C did not significantly (ϕ = 95%) differ from the reference at room 
temperature. At 50°C, though a significant activity decrease of more than 13% was detected 
compared to the reference. The statistical significance must be kept with caution, though, because 
the standard deviations of these two data points varied. 
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These investigations showed that dissolved enzyme powder was less stable than dry enzyme 
powder. This effect is obvious especially at stress temperatures higher than 40°C. Although in 
general enzymes are known to be more stable in dry state than in solutions (Hageman, 1992), it 
must also be kept in mind, that the exposure time in these two experiments was not the same. The 
exposure time for the dry enzyme powder was 10 min compared to 30 min for the enzyme 
solutions. Moreover the enzyme solutions had to cool to room temperature before the enzyme 
activity was detected. This cooling time was dependent on the stress temperature and lasted 2 to 3 
hours. A possible negative effect of this cooling time on the enzyme activity is imaginable. It has to 
be mentioned that the lack of activity at stress temperatures higher than 50°C is at variance with 
literature data (Uhlig, 1998). Nevertheless, for further use of enzyme solutions, for example as 
binding agent solution for granulation and pellet coating, exposure temperatures higher than 50°C 
should be avoided.  
 
 
5.1.2 Excipients 
 
The behavior of the activity of β-galactosidase in the presence of various excipients was 
investigated and compared to the activity of bulk β-galactosidase powder as a reference (Fig. 5.3). 
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Fig. 5.3: Activity of β-galactosidase in the presence of excipients (n = 3). Error bars: ± 1 
standard deviation.  
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The difference between the reference and the solutions of β-galactosidase powder and excipient, 
i.e. microcrystalline cellulose, dicalcium phosphate dihydrate, sucrose and maize starch was 
statistically not significant. Hence, influence of these excipients on the activity of β-galactosidase is 
not evident.  
 
Hydroxy propyl methylcellulose at the contrary shows a significant influence on the activity of β-
galactosidase powder. An activity increase of more than 37% was measured. A hydroxy propyl 
methylcellulose solution in the same concentration but without addition of enzyme powder had an 
absorption value of zero. Thus, β-galactosidase activity is directly influenced by the polymer 
excipient hydroxy propyl methylcellulose. The polymer is supposed to have a stabilizing effect on 
the enzyme. It protects the dissolved enzyme from denaturation and increases therefore the 
stability of the enzyme in solution. Stabilizing effects of polymers, antioxidants and other 
substances on enzymes are described by Halbeisen (1993) and Pikal-Cleland and Carpenter 
(2001).  
 
The different excipients investigated can be used together with the enzyme preparation without the 
risk of a negative influence on the enzyme activity. The stabilizing effect of the polymer is even 
expected to have positive influences on the stability of the binding agent solutions for granulation 
and pellet coating.  
 
 
5.2 Granulates and Pellets 
 
The granulation and pellet coating processes have been accomplished to see if the film building 
behavior of the enzyme powder preparation is influenced by the raw material that was coated. For 
that reason, the treatment of the substances, the process parameters and the composition of the 
binding agent solution were kept as constant as possible to be able to make any comparisons 
between the four products produced. It was the aim to compare four different raw materials. For 
that reason the raw materials chosen had to fulfill other claims than normal raw materials for 
granulation. First of all, brittle raw material was compared to plastic raw material and these two 
material characteristics have been used in formation of regular formed particles with a smooth 
surface, i.e. pellets and irregular formed particles with a rough surface (Tab. 5.1).  
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Tab. 5.1: Raw materials used for enzyme coating. 
 
brittle plastic
regular formed,
smooth surface sugar pellets microcrystalline cellulose pellets
irregular formed,
rough surface dicalcium phosphate dihydrate microcrystalline cellulose
 
 
 
These four raw materials have been coated with a β-galactosidase binding agent solution. It is 
necessary to mention that not the quality of the granulate, but the coating of the particles was 
decisive.  
 
The necessary amount of β-galactosidase binding agent solution to spray on the raw material was 
calculated according to a theoretical l-value of two for the powders and five for the pellets. 
Therefore the duration of the spraying process was variable, i.e. dependent on the necessary 
amount of binding agent solution and the spraying rate, which was higher for the pellets than for 
the powders. Tab. 5.2 gives an overview of these different conditions. General process parameters 
are described in chapters 4.4 and 4.5. 
 
 
Tab. 5.2: Overview of the process time for particle coating. 
 
Preparation Spray rate (g/min) Amount of binding agent solution (g) Process time (min)
β-Galactosidase- 2.3 271.2 117.9
microcrystalline cellulose
granulate
β-Galactosidase- 2.3 156.7 68.1
dicalcium phosphate dihydrate
granulate
β-Galactosidase- 2.6 431.0 165.8
microcrystalline cellulose 
pellets
β-Galactosidase- 2.6 204.3 78.6
sugar
pellets
 
 
 
The yield of the end product was 88.6% for the β-galactosidase-microcrystalline cellulose 
granulate, 84.5% for the β-galactosidase-dicalcium phosphate dihydrate granulate, 87.4% for the β-
Results and Discussion 
 50  
galactosidase-microcrystalline cellulose pellets and 95.1% for the β-galactosidase-sugar pellets, 
respectively.  
 
Detailed information about the character of the various preparations and the influence of the 
coating process on the activity of the end products is given in the following chapters.  
 
 
5.2.1 Characterization of granulates and pellets 
 
An overview of the characterization of the granulates and pellets as well as the raw materials is 
given in Tab. 5.3. 
 
 
Tab. 5.3: Characterization of granulate and pellet preparations and raw materials. 
 
Substance/Preparation Densities Mean Median
True Poured ρ p particle particle
(g/ml) (g/ml) (rel) size (µm) size (µm)
Microcrystalline cellulose 1.55 0.325 0.210 162.8 142.0
Dicalcium phosphate dihydrate 2.38 0.926 0.389 187.3 182.1
Microcrystalline cellulose pellets 1.37 0.831 0.607 476.9 469.3
Sugar pellets 1.56 0.839 0.537 456.1 451.0
β-Galactosidase-MCC granulate 1.47 0.307 0.208 400.1 369.3
β-Galactosidase-DCP granulate 2.02 0.895 0.442 237.7 227.7
β-Galactosidase-MCC pellets 1.41 0.836 0.594 574.1 544.5
β-Galactosidase-sugar pellets 1.45 0.858 0.590 515.1 501.4
 
 
 
The difference between the mean particle size and the median particle size of the pellets and 
granulates shows that the coating caused a broader particle size distribution, but the differences 
between the mean and the median values are still relatively small, which means that for all 
substances the layering is regularly distributed on the preparations.  
 
 
The scanning electron microscopy pictures show the differences between the two granulate types. 
β-Galactosidase-microcrystalline cellulose granulate is formed very irregular (Fig. 5.1). On the one 
hand there can be found small particles similar to the raw material that was coated by the binding 
agent and on the other hand there are also some bigger agglomerates, showing real granulate 
forming. Moreover it can be seen that the surface of these granulate particles is very rough (Fig. 
5.2).  
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Fig. 5.1: SEM picture of β-galactosidase-MCC granulate (50x). 
 
 
 
 
Fig. 5.2: SEM picture of β-galactosidase-MCC granulate (250x). 
 
 
β-Galactosidase-dicalcium phosphate dihydrate granulate at the contrary is formed very regular 
(Fig. 5.3) and the surface of the granulate particles is very smooth (Fig. 5.4).  
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Fig. 5.3: SEM picture of β-galactosidase-DCP granulate (50x). 
 
 
 
 
Fig. 5.4: SEM picture of β-galactosidase-DCP granulate (250x). 
 
 
The scanning electron microscopy pictures of the raw and coated pellets give interesting 
information as well. The regular surface of the uncoated microcrystalline cellulose pellet (Fig. 5.5) 
got very smooth with the coating (Fig. 5.6).  
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Fig. 5.5: SEM picture of microcrystalline cellulose pellet (200x). 
 
 
 
 
Fig. 5.6: SEM picture of β-galactosidase-MCC pellet (100x). 
 
 
The surface of the uncoated sugar pellet (Fig. 5.7) was similar to the surface of the uncoated 
microcrystalline cellulose pellet and the coating lead to a rougher, more irregular surface (Fig. 5.8). 
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Fig. 5.7: SEM picture of sugar pellet (150x). 
 
 
 
 
Fig. 5.8: SEM picture of β-galactosidase-sugar pellet (150x). 
 
 
The difference in the state of these coating films (Fig. 5.9, Fig. 5.10, Fig. 5.11, Fig. 5.12) is 
supposed to be caused by the porosity and water absorption properties of the raw materials. 
Microcrystalline cellulose powder is known to absorb water during granulation processes, 
microcrystalline cellulose pellets are very compact and have a very small porosity. Sugar pellets at 
the contrary are more porous and can absorb water. The difference in the state of these two pellet 
types can also be seen in the cross-section pictures of the coated pellets (Fig. 5.13, Fig. 5.14). 
Dicalcium phosphate dihydrate is also a very compact substance, which does not absorb water 
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during granulation processes. Probably the fast elimination of the water in the binding agent 
solution by absorption during the spraying process prevents the formation of a smooth and regular 
coating film.  
 
 
 
 
Fig. 5.9: SEM picture of the surface of β-galactosidase-MCC granulate (2000x). 
 
 
 
 
Fig. 5.10: SEM picture of the surface of β-galactosidase-MCC pellet (2000x). 
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Fig. 5.11: SEM picture of the surface of β-galactosidase-sugar pellet (2000x). 
 
 
 
 
Fig. 5.12: SEM picture of the surface of β-galactosidase-DCP granulate (2000x). 
 
 
The effective l-values were 1.3 for the β-galactosidase-microcrystalline cellulose granulate, 0.6 for 
the β-galactosidase-dicalcium phosphate dihydrate granulate, 3.0 for the β-galactosidase-
microcrystalline cellulose pellets and 4.2 for the β-galactosidase-sugar pellets, respectively.  
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Fig. 5.13: SEM picture of the cross-section of β-galactosidase-MCC pellet (500x). 
 
 
 
 
Fig. 5.14: SEM picture of the cross-section of β-galactosidase-sugar pellet (500x). 
 
 
The growth of the particle size was 50.3 µm for the β-galactosidase-dicalcium phosphate dihydrate 
granulate and 237.8 µm for the β-galactosidase-microcrystalline cellulose granulate, respectively. 
This result shows that in the second granulate relatively big agglomerates have been formed. The 
growth of particle size of the pellets can be verified with the cross-section SEM-pictures (Fig. 5.13, 
Fig. 5.14) and was 97.2 µm for the β-galactosidase-microcrystalline cellulose pellets and 59.0 µm 
for the β-galactosidase-sugar pellets, respectively.  
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5.2.2 Influence of granulation and pellet coating on enzyme activity 
 
Determination of the enzyme content of the layered preparations was accomplished with a 
measurement of the total protein content. The total protein content of the β-galactosidase powder 
preparation was 14.6% measured with the Lowry protein assay. Based on that result, the β-
galactosidase powder content of the preparations was calculated to be 8.9% for the β-
galactosidase-microcrystalline cellulose granulate, 2.3% for the β-galactosidase-dicalcium 
phosphate dihydrate granulate, 6.3% for the β-galactosidase-microcrystalline cellulose pellets and 
10.9% for the β-galactosidase-sugar pellets. The content of total protein in the β-galactosidase 
powder preparation was very low compared to the value of 40% declared by the supplier. It is 
supposed that this difference occurred due to the reference used in the Lowry protein assay. Lowry 
et al. (1951) reported that the amount of color can vary with different proteins. This variation is a 
reflection of the contribution of specific amino acids, mainly of tyrosine and tryptophan (Sapan et 
al., 1999). As it was impossible to get pure β-galactosidase from the same source like the used 
β−galactosidase preparation to have an exact reference, bovine serum albumin was used, which is 
a generally used reference for standard protein tests. Nevertheless the actual yield of β-
galactosidase powder in the preparations could be calculated and was found to be 43.0% for the β-
galactosidase-microcrystalline cellulose granulate, 15.7% for the β-galactosidase-dicalcium 
phosphate dihydrate granulate, 37.1% for the β-galactosidase-microcrystalline cellulose pellets and 
61.4% for the β-galactosidase-sugar pellets, respectively.  
 
The activity of the preparations was also detected. Tab. 5.4 gives an overview of the activity 
increase after coating.  
 
 
Tab. 5.4: Overview of the activity increase after coating. 
 
Preparation Activity increase after coating (%)
β-Galactosidase-MCC granulate 252.5 (+/- 23.7)
β-Galactosidase-DCP granulate 548.6 (+/- 22.2)
β-Galactosidase-MCC pellets 265.9 (+/- 16.8)
β-Galactosidase-sugar pellets 127.8 (+/- 9.0)
 
 
 
The activity increase for all preparations is very high. Probably due to two factors being involved in 
the granulation and pellet coating process: temperature arise and presence of binding agent. 
Temperature increase up to 50°C and the presence of hydroxy propyl methylcellulose do have 
positive influence on the behavior of the activity of the enzyme β-galactosidase. The extent of 
activity increase of the four preparations is very different, but it may not be correlated to the 
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process time (Tab. 5.2). It is supposed that the extent of activity increase is dependent on the 
quality of the coating film. The preparations with rough surfaces, i.e. β-galactosidase-
microcrystalline cellulose granulate (Fig. 5.9) and β-galactosidase-sugar pellets (Fig. 5.11) show an 
activity increase of 252.5% and 127.8%, respectively. While the preparations with smooth surfaces, 
i.e. β-galactosidase-microcrystalline cellulose pellets (Fig. 5.10) and β-galactosidase-dicalcium 
phosphate dihydrate granulate (Fig. 5.12) show an activity increase of 265.9% and 548.6%, 
respectively. Taking into account that the binding agent solution sprayed on the β-galactosidase-
microcrystalline cellulose pellets was diluted (1:1), the extent of activity increase can be associated 
with the quality of the coating film. Probably the viscosity of the binding agent solution is 
responsible for the degree of protection of the enzyme. It is conceivable that the polymer film 
protects the enzyme molecules from the hydrolytic covalent reactions observed in aqueous 
solutions and leads to an increased conformational rigidity (Volkin and Middaugh, 1992).  
 
 
5.3 Compression behavior of powder and powder mixtures 
 
The characterization of the enzyme powder preparation and mixtures of the preparation with the 
plastic excipient microcrystalline cellulose and the brittle excipient dicalcium phosphate dihydrate, 
respectively was done by the use of Heckel and modified Heckel equation. The yield strength of the 
mixtures was also analyzed. The activity loss of the compacted powder was investigated and 
correlated with the corresponding tablet porosities.  
 
The interpretation of the Heckel plots showed some difficulties because it is necessary to define the 
linear range of a curve to get exact data about the compression properties of a substance. It is 
known that plastic substances show a small bend indicating a particle rearrangement followed by a 
linear segment, which can be followed by a flattened segment at very high compaction pressures. 
Brittle substances at the contrary show a distinct bend at the beginning of the compression 
followed by a linear range with a smaller slope than for plastic particles. For that reason after 
characterization the behavior of the substances in the Heckel plot the calculation of the K value 
was only done within a chosen compression range. The linear range of plastic materials was 
chosen to be between 40 and 199 MPa, whereas the linear range of brittle materials was defined 
between 100 and 398 MPa. With this differentiation a very exact description of the compression 
behavior was done but the problem was that there resulted kind of subjective characterization 
based on the forming of the curves in the Heckel plot. To prevent misinterpretation K values were 
also calculated from the whole date range and although the squared correlation coefficient was 
worse in this cases the general tendencies could always be confirmed. For the interpretation of the 
mixtures K values for both data ranges were calculated and the range with the higher squared 
correlation coefficient was chosen for the interpretation.  
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5.3.1 β-Galactosidase powder 
 
The slope of a Heckel plot characterizes the compression behavior of a powder. The behavior of β-
galactosidase powder was characterized in comparison with the excipients microcrystalline 
cellulose and dicalcium phosphate dihydrate, which show typical behavior for plastic and brittle 
properties, respectively. A Heckel plot of these three bulk materials is shown in Fig. 5.15. 
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Fig. 5.15: Heckel plots of bulk materials, comparison of β-galactosidase, microcrystalline 
cellulose and dicalcium phosphate dihydrate. 
 
 
Fig. 5.15 shows that the two bulk substances β-galactosidase and dicalcium phosphate dihydrate 
behave very similar. Contrary to that the behavior of microcrystalline cellulose is obviously different. 
As dicalcium phosphate dihydrate is known to have brittle properties, β-galactosidase powder can 
be classified as brittle substance. Calculation of the K values indicating the slope of the curves also 
confirms that statement. K values of β-galactosidase and dicalcium phosphate dihydrate are 
0.00373 MPa-1 (R2 = 0.961) and 0.00241 MPa-1 (R2 = 0.997), respectively, whereas the K value of 
microcrystalline cellulose is 0.01288 MPa-1 (R2 = 0.983). The use of out-of-die values has the 
disadvantage that much less data points are obtained. Nevertheless the similarity of the K values 
for β-galactosidase and dicalcium phosphate dihydrate is obvious and the K value for 
microcrystalline cellulose confirms the fact that plastic substances have higher K values than brittle 
substances.  
 
A plot of the compaction pressure versus the relative density (Fig. 5.16, Fig. 5.17) and the 
interpretation with the modified Heckel equation (Eq. (3.12)) confirm these results. 
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Fig. 5.16: Compaction pressure σ as a function of the relative density. Comparison of β-
galactosidase, microcrystalline cellulose and dicalcium phosphate dihydrate. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.17: Compaction pressure σ as a function of the relative density with β-galactosidase, 
microcrystalline cellulose and dicalcium phosphate dihydrate (from left to right). 
The solid line represents the model according to Eq. (3.12). 
 
 
C values for β-galactosidase and dicalcium phosphate dihydrate are with values of 0.00040 MPa-1 
(R2 = 0.897) and 0.00058 MPa-1 (R2 = 0.924) quite low and lie near together. The C value for 
microcrystalline cellulose is with 0.00114 MPa-1 (R2 = 0.701) much higher, indicating a plastic 
powder behavior. The lower value for the squared correlation coefficient of microcrystalline 
cellulose can be explained with the low number of data points in the region of lower compaction 
pressures, which have more influence on the plastic powder behavior. Generally the interpretation 
with the modified Heckel plot was difficult because this model describes mainly the transition 
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between the state of a powder and the state of a tablet. For that reason the lack of data points at 
very low compaction pressures complicated the interpretation.  
 
A further characterization of the behavior of the enzyme powder under compression was done by 
investigation of the activity loss (Fig. 5.18). 
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Fig. 5.18: Comparison of activity loss and tablet porosity of bulk β-galactosidase tablets (n = 
5). Error bars: ± 1 standard deviation. 
 
 
The activity decreased steadily up to a compaction pressure of 199 MPa, at higher compaction 
pressures, the curve flattened and the degree of the activity loss decreased. A comparison with the 
porosity of the tablets showed that the curve also flattened slightly after the pressure of 199 MPa. 
This statement was proved with the partition of each curve into two parts by non-linear regression. 
For both curves the partition between 199 and 298 MPa showed highest squared correlation 
coefficients R2 with 0.962 for the activity curve and 0.937 for the porosity curve. The slopes in the 
first sections were –0.157 for the activity curve and –0.176 for the porosity curve, respectively 
whereas the slopes in the second sections were –0.009 for the activity curve and –0.006 for the 
porosity curve, respectively.  
 
The correlation coefficient r (Eq. (4.7)) of these two curves showed a value of 0.965 proofing a 
positive correlation. This correlation can be explained with the reduction of interparticle space, 
which is big in the stage of particle movement and rearrangement and diminishes in the stage of 
particle deformation and therefore by a destruction of the native state of the enzyme under 
compression. This destruction is probably linear in the stage of particle movement and 
rearrangement. In the stage of deformation, i.e. the region of the flattening slope, shearing forces 
will probably decrease as a consequence of the reduced particle movement. Teng and Groves 
(1988) found a similar behavior for urease and proposed that at a certain compression stadium the 
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amount of denatured protein is already high and can protect the native protein due to a higher 
resistance to shear. Although a higher resistance to shearing forces from denatured proteins 
compared to native proteins is not proved.  
 
 
5.3.2 Mixture with plastic excipient 
 
A comparison of the bulk materials, β-galactosidase and microcrystalline cellulose, with a mixture 
of 50% (w/w) of each of the two substances showed that there is no linear behavior but there can 
be seen a slight dominance of β-galactosidase powder in the Heckel plot (Fig. 5.19).  
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Fig. 5.19: Heckel plots of bulk β-galactosidase and microcrystalline cellulose and their 
mixture (50:50). 
 
 
The calculation of the C value (Eq. (3.12)) of 0.00068 MPa-1 (R2 = 0.847) of this 50% mixture 
confirmed that statement. Interpretation of the K value, though was difficult because the result was 
depending on the linear region chosen for the calculation (Eq. (3.3)). Calculation of the K value in 
the range of 100-398 MPa for brittle substances led to a value of 0.00489 MPa-1 (R2 = 0.972) 
confirming the interpretation resulting from considering the Heckel plot, i.e. the behavior of the 
mixture is dominated by the bulk β-galactosidase powder. Calculation of the K value in the range of 
40-199 MPa for plastic substances, though resulted in a value of 0.00866 MPa-1 (R2 = 0.988), 
obviously with higher squared correlation coefficient. To prevent misinterpretation, the K values of 
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the three substances, β-galactosidase powder, microcrystalline cellulose and their 50% mixture 
have been recalculated over the whole compression range (without relative densities higher than 
0.95). Resulting in the following K values: 0.00465 MPa-1 (R2 = 0.947) for β-galactosidase, 0.02004 
MPa-1 (R2 = 0.944) for microcrystalline cellulose and 0.00690 MPa-1 (R2 = 0.944) for the mixture.  
 
These results demonstrate the difficulties and also the weakness of the use of Heckel equation for 
the characterization of substances. The K value for the slope can strongly vary with the linear 
range defined for the calculation.  
 
The yield strength of all binary mixtures was calculated from the K values with the highest squared 
correlation coefficient (Eq. (3.5)) and plotted in Fig. 5.20. 
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Fig. 5.20: Yield strength of the mixtures of bulk β-galactosidase and microcrystalline 
cellulose. 
 
 
Looking at the yield strength behavior of plastic-brittle mixtures it can be seen that the system 
shows a change in behavior in the region of an amount of enzyme powder of 70%. Below that 
concentration of enzyme powder, the tendency of the compressed material to undergo deformation 
is dominated by the plastic material. This result indicates that microcrystalline cellulose forms an 
“infinite” cluster for concentrations above 30% (w/w). Thus according to Fig. 5.20 there is a 
percolation threshold between 70-80% (w/w) of β-galactosidase.  
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5.3.3 Mixture with brittle excipient 
 
The comparison of two brittle bulk materials, namely β-galactosidase powder and dicalcium 
phosphate dihydrate with their 50% (w/w) mixture showed a negative deviation of the mixture from 
the bulk substances (Fig. 5.21). 
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Fig. 5.21: Heckel plots of bulk β-galactosidase and dicalcium phosphate dihydrate and their 
mixture (50:50). 
 
 
Calculation of the K value (Eq. (3.3)) and the C value (Eq. (3.12)) of the 50% mixture, whereas the 
K value was 0.00257 MPa-1 (R2 = 0.918) and the C value was 0.00024 MPa-1 (R2 = 0.872), showed 
that the slope of the mixture was almost the same as the slope of the bulk substance dicalcium 
phosphate dihydrate. Densification properties of different brittle particles seem to be very similar 
and have no big influences on each other.  
 
Calculation of the yield pressure of all binary mixtures from the K values (Eq. (3.5)) confirm that 
statement (Fig. 5.22). 
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Fig. 5.22: Yield strength of the mixtures of bulk β-galactosidase and dicalcium phosphate 
dihydrate. 
 
 
Although there are some irregularities in this curve the general tendency for the mixtures is the 
same as for the bulk substances and therefore it can be said that mixtures of brittle substances do 
not change their deformation behavior compared to the bulk substances of the mixtures. Due to the 
fact that both substances have similar yield strength it is not surprising that it is difficult to detect a 
percolation threshold.  
 
 
5.4 Compression behavior of granulates 
 
The produced granulates were not fractionated before compression. The reason was to have an 
irregular product as a contrast to the very regular product of coated pellets.  
 
The compression behavior was characterized by investigation of the Heckel plots. In addition, the 
behavior of the enzyme activity under pressure was detected and correlated with the porosity of the 
compacts.  
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5.4.1 Granulate from plastic excipient 
 
The comparison of the behavior of the β-galactosidase-microcrystalline cellulose granulate and the 
microcrystalline cellulose powder in the Heckel plot (Fig. 5.23) shows that the produced granulate 
had the same plastic properties like its raw material microcrystalline cellulose.  
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Fig. 5.23: Heckel plots of microcrystalline cellulose and β-galactosidase-microcrystalline 
cellulose granulate. 
 
 
The slope indicated a plastic behavior with a K value of 0.01288 MPa-1 (R2 = 0.983) for 
microcrystalline cellulose powder and 0.01318 MPa-1 (R2 = 0.989) for β-galactosidase-
microcrystalline cellulose granulate.  
 
The behavior of the activity as well as the porosity of the granulate compacts are shown in Fig. 
5.24. 
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Fig. 5.24: Comparison of activity loss and tablet porosity of β-galactosidase-microcrystalline 
cellulose granulate (n = 10). Error bars: ± 1 standard deviation. 
 
 
The activity at maximum compaction pressure was 75.9% at a porosity of –0.4%. The negative 
porosity can be explained with a total compression of the compact to zero porosity, the deviation 
towards a negative value is probably caused by inaccuracy of the measurement. The relative 
density of the compacts and thus the porosity was calculated from the weight and the thickness of 
the compacts, variability from the balance and the measurement with the thickness gauge are 
possible. The high standard deviations are probably caused by the irregularity of the compacted 
granules. The activity decrease of the compacted granulate was smaller than the maximum activity 
decrease from compacted β-galactosidase powder, which was 46.7% at a porosity of 4.1%. The 
correlation coefficient r (Eq. (4.7)) of the correlation of the activity and the porosity curve of the 
granulate was 0.959. Obviously the forming of the curves is still correlated and thus the activity loss 
is dependent on the tablet porosity. The fact that the activity loss of the compacted enzyme powder 
was higher with a higher final porosity suggests further influences on the activity under 
compression. It is conceivable that the deformation properties of the particles as well as their size 
and shape additionally influence the activity loss. 
 
 
5.4.2 Granulate from brittle excipient 
 
The interpretation of the Heckel plots (Fig. 5.25) of the β-galactosidase-dicalcium phosphate 
dihydrate granulate and the raw material dicalcium phosphate dihydrate showed that the 
deformation properties of the granulate were more plastic than its brittle raw material. The K value 
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was 0.00241 MPa-1 (R2 = 0.997) for dicalcium phosphate dihydrate powder and 0.00785 MPa-1 (R2 
= 0.993) for β-galactosidase-dicalcium phosphate dihydrate granulate. This behavior was 
expected, since granulates are known to have better compression properties than powders, 
especially when the powders show brittle properties. 
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Fig. 5.25: Heckel plots of dicalcium phosphate dihydrate and β-galactosidase-dicalcium 
phosphate dihydrate granulate. 
 
 
The measured activity at maximum compaction pressure (1194 MPa) was 61.2% at a porosity of   
–2.1%. At the very high compaction pressure of 1194 MPa there was again reached zero porosity. 
The behavior of the activity and the porosity of the compacted granulate over the whole 
compression range is shown in Fig. 5.26. 
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Fig. 5.26: Comparison of activity loss and tablet porosity of β-galactosidase-dicalcium 
phosphate dihydrate granulate (n = 10). Error bars: ± 1 standard deviation. 
 
 
Positive correlation was proved again with the correlation of the activity and the porosity curves 
with a correlation coefficient r of 0.948. The activity loss seemed to depend again on the tablet 
porosity. The activity at maximum pressure (61.2%) was lower than in the compacted β-
galactosidase-microcrystalline cellulose granulate (75.9%), but higher than in the compacted 
enzyme powder (46.7%). These results are consistent with the degree of deformation properties 
defined with Heckel equation, where the K value was 0.00785 MPa-1 (R2 = 0.993) for β-
galactosidase-dicalcium phosphate dihydrate granulate, 0.01318 MPa-1 (R2 = 0.989) for β-
galactosidase-microcrystalline cellulose granulate and 0.00373 MPa-1 (R2 = 0.961) for β-
galactosidase powder, respectively. The activity at maximum pressure of these three preparations 
was plotted against the K values (Fig. 5.27) and the correlation coefficient R2 of the regression line 
of these three data points was 0.995, indicating dependence between the compression behavior 
and the activity loss under pressure.  
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Fig. 5.27: Comparison of the activity at maximum pressure (1194 MPa) and the K values of 
the investigated β-galactosidase granulates and the β-galactosidase powder.  
 
 
A comparison of the behavior of the activity under pressure of the enzyme powder and the two 
different enzyme granulate preparations is given in Fig. 5.28. 
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Fig. 5.28: Comparison of the activity loss in the compacted enzyme granulates and enzyme 
powder.  
 
 
It is obvious that especially at higher compaction pressures the activity loss in the compacted 
enzyme powder was higher than in the compacted β-galactosidase-dicalcium phosphate dihydrate 
granulate. The lowest activity loss was found in the compacted β-galactosidase-microcrystalline 
cellulose granulate.  
 
 
5.5 Compression behavior of pellets 
 
The compression behavior of the uncoated raw pellets and the enzyme-coated pellets was 
investigated and compared. This characterization was done with Heckel equation and the 
interpretation of scanning electron microscopy pictures. The activity loss of the compacted enzyme 
pellets was also measured and correlated with the porosity of the compacts.  
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5.5.1 Pellets from plastic excipient 
 
The Heckel plots of the raw microcrystalline cellulose pellets and the coated β-galactosidase-
microcrystalline cellulose pellets are shown in Fig. 5.29. 
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Fig. 5.29: Heckel plots of raw microcrystalline cellulose pellets and coated β-galactosidase-
microcrystalline cellulose pellets. 
 
 
The interpretation of these Heckel plots and the calculation of the K values was difficult, because 
there were no data points below a compaction pressure of 100 MPa besides the data for relative 
poured density at zero pressure. Generation of out-of-die data requires the production of stable 
compacts, which was only possible in this case at compaction pressures higher than 100 MPa. Due 
to the lack of data points at lower compaction pressures, there is no information about the particle 
rearrangement behavior, i.e. the presence of a bend in the curve. Such a behavior is typical for 
pellets as the spherical pellets are arranged immediately, i.e. without the application of a pressure 
> 0. Moreover, at a compaction pressure of 199 MPa the curves flattened, because there was no 
further densification possible. The zero porosity was already reached at that compaction pressure. 
For the calculation of the K value the compression range between 0 and 199 MPa was used with a 
resulting K value of 0.01128 MPa-1 (R2 = 0.996) for microcrystalline cellulose pellets and 0.01507 
MPa-1 (R2 = 0.928) for β-galactosidase-microcrystalline cellulose pellets.  
 
These results have been confirmed looking at the arrangement and deformation of the pellets in 
the compacts with a scanning electron microscope (Fig. 5.30, Fig. 5.31, Fig. 5.32, Fig. 5.33, Fig. 
5.34).  
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Fig. 5.30: SEM picture of the surface of a compact of β-galactosidase-microcrystalline 
cellulose pellets at a compaction pressure of 100 MPa (50x). 
 
 
 
 
Fig. 5.31: SEM picture of the surface of a compact of β-galactosidase-microcrystalline 
cellulose pellets at a compaction pressure of 199 MPa (50x). 
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Fig. 5.32: SEM picture of the surface of a compact of β-galactosidase-microcrystalline 
cellulose pellets at a compaction pressure of 1194 MPa (50x). 
 
 
 
 
Fig. 5.33: SEM picture of the surface of a compact of microcrystalline cellulose pellets at a 
compaction pressure of 1194 MPa (50x). 
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Fig. 5.34: SEM picture of the cross-section of a compact of microcrystalline cellulose pellets 
at a compaction pressure of 1194 MPa (50x). 
 
 
The comparison of the behavior of the coated enzyme pellets at compaction pressures of 100, 199 
and 1194 MPa on the surface of the compacts showed that there was only low porosity detectable 
at 100 MPa, which was fast decreasing and totally disappeared at the highest compaction pressure 
applied. The behavior of the compacted raw pellets did not differ (Fig. 5.33, Fig. 5.34). The cross-
section of the compact illustrates the loss of porosity with a deformation of the pellets. It is also 
obvious that the pellets only changed their shape but did not break. Probably, there are tendencies 
that the coating promoted the plastic deformation capacity of the pellets, which could not be seen in 
the SEM pictures, but the slightly higher K value and the higher stability observed on the compacts 
from the coated pellets led to that supposition.  
 
The investigation of the activity loss under pressure and the correlation with the porosity of the 
compacted β-galactosidase-microcrystalline cellulose pellets resulted in the data plotted in Fig. 
5.35. 
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Fig. 5.35: Comparison of activity loss and tablet porosity of β-galactosidase-microcrystalline 
cellulose pellets (n = 5). Error bars: ± 1 standard deviation. 
 
 
Although zero porosity was reached very fast, the forming of the activity curve was distinctly 
different to the activity curves of the other substances investigated. The activity loss at maximum 
compaction pressure was 89.3% at a porosity of –6.8%. It is supposed that the activity is stable 
over the whole compression range, because there was no constant activity decrease detectable. 
The unsteadiness of the standard deviations of the various data points, which is normal for enzyme 
assays, makes the interpretation of statistical significance difficult.  
 
The calculation of the correlation between the activity and the porosity curve (Eq. (4.7)) led to a 
correlation coefficient r of 0.493. This value reflects the bad correlation between these two curves. 
The compression of a mixture of β-galactosidase-microcrystalline cellulose pellets with 
microcrystalline cellulose pellets in a mixture ratio of 50% each under the same assay conditions 
showed an activity of 94.5% at maximum compaction pressure and a porosity of –6.9%. The 
correlation coefficient r was 0.402. These results were consistent with the compacted β-
galactosidase-microcrystalline cellulose pellets. Obviously there was no difference in the 
compression of bulk β-galactosidase-microcrystalline cellulose pellets and the compression of a 
50% mixture of the same bulk enzyme pellets with the raw microcrystalline cellulose pellets. The 
absence of a significant activity loss during compression of pellets from a plastic raw material can 
probably be explained on the one hand again by the plastic properties seen in the Heckel plot, 
because obviously there is a positive effect of plastic compression properties on the behavior of the 
activity under pressure. On the other hand there must be an additional effect explaining the total 
absence of activity loss. It is supposed that the special deformation character of the pellets protects 
the enzyme. The fact that the pellets do not break and the various pellets keep their individuality 
although they fit their form to reach maximum packaging (Fig. 5.32) causes very low shearing 
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forces. The round shaped, regular particles get not pushed into each other. The size and the shape 
of the individual particles are the same due to the regularity of the pellets, thus they cannot 
influence each other under pressure.  
 
 
5.5.2 Pellets from brittle excipient 
 
The Heckel plots of the sugar pellets and the β-galactosidase-sugar pellets are shown in Fig. 5.36. 
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Fig. 5.36: Heckel plots of raw sugar pellets and coated β-galactosidase-sugar pellets. 
 
 
The compression behavior of both pellets was the same in the Heckel plot, the lack of a distinct 
bend indicated plastic properties. The K value calculated between compaction pressures of 0-199 
MPa was 0.00968 MPa-1 (R2 = 0.944) for the sugar pellets and 0.01008 MPa-1 (R2 = 0.981) for the 
β-galactosidase-sugar pellets. The enzyme coating did not seem to have any influences on the 
compression behavior of the sugar pellets.  
 
The behavior of the single pellets in the compacts was investigated by interpretation of the 
scanning electron microscopy pictures (Fig. 5.37, Fig. 5.38, Fig. 5.39, Fig. 5.40, Fig. 5.41, Fig. 
5.42, Fig. 5.43). 
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Fig. 5.37: SEM picture of the surface of a compact of β-galactosidase-sugar pellets at a 
compaction pressure of 40 MPa (50x). 
 
 
 
 
Fig. 5.38: SEM picture of the surface of a compact of β-galactosidase-sugar pellets at a 
compaction pressure of 199 MPa (50x). 
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Fig. 5.39: SEM picture of the cross-section of a compact of β-galactosidase-sugar pellets at a 
compaction pressure of 199 MPa (50x). 
 
 
 
 
Fig. 5.40: SEM picture of the surface of a compact of β-galactosidase-sugar pellets at a 
compaction pressure of 1194 MPa (50x). 
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Fig. 5.41: SEM picture of the surface of a compact of sugar pellets at a compaction pressure 
of 199 MPa (50x). 
 
 
 
 
Fig. 5.42: SEM picture of the cross-section of a compact of sugar pellets at a compaction 
pressure of 199 MPa (50x). 
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Fig. 5.43: SEM picture of the surface of a compact of sugar pellets at a compaction pressure 
of 1194 MPa (50x). 
 
 
The kind of deformation of the sugar pellets under compression was different to the kind of 
deformation of the microcrystalline cellulose pellets, although the K value of the Heckel equation 
was very similar for all types of pellets investigated. Obviously the sugar pellets built cracks at the 
surface under pressure. Although the pellets did not break and the single pellets could be still 
distinguished in the cross-section (Fig. 5.39) the demarcation between the particles slightly 
disappeared. It is conceivable that with the fracture at the surface of the pellets the surface got 
rough and some powder particles of different size and shape were built. These particles could be 
pushed into each other. The surface of the coated pellets was more stable since the degree of 
cracking was smaller than within the uncoated pellets. Therefore the pushing of the fractured 
particles at the pellet surface into each other was bigger (Fig. 5.41, Fig. 5.42) and resulted in a 
compact, amorphous mass at the highest compaction pressure of 1194 MPa (Fig. 5.43).  
 
The extent of the activity loss and the development of the porosity in the pellet compacts was again 
compared (Fig. 5.44). 
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Fig. 5.44: Comparison of activity loss and tablet porosity of β-galactosidase-sugar pellets (n = 
10). Error bars: ± 1 standard deviation. 
 
 
The activity measured at maximum compaction pressure was 77.6% with a porosity of -5.25%. The 
correlation coefficient r of the two curves was 0.821. The correlation of the activity and the porosity 
curve of the compacted β-galactosidase sugar pellets was worse than the correlation of these two 
curves from the powder and granulate products, but better than the correlation of the two curves 
from the compacted β-galactosidase-microcrystalline cellulose pellets. Obviously the building of 
powder particles at the surface of the various pellets caused by the cracking leads to an enhanced 
number of shearing forces. Due to that reason the activity loss is higher than within the compacted 
β-galactosidase-microcrystalline cellulose pellets. But the fact that the pellets did not break and 
only slightly changed their shape although the demarcation between the single pellets disappeared 
seemed to cause smaller shearing forces than the one built during the compression of powders 
and granulates.  
 
A comparison of the behavior of the activity under pressure of the enzyme powder and the two 
different enzyme pellet preparations is given in Fig. 5.45. 
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Fig. 5.45: Comparison of the activity loss in the compacted enzyme pellets and enzyme 
powder.  
 
 
It is obvious that the compacted enzyme powder showed a steady activity loss, while the 
compacted β-galactosidase-microcrystalline cellulose pellets did not show significant activity loss. 
The compacted β-galactosidase-sugar pellets showed no significant activity decrease between 0 
and 120 MPa. At 140 MPa though there was a significant change in the behavior of the activity 
probably because the built powder particles at the surface of the pellets started to get pushed into 
each other. Between the compaction pressures of 199 and 1194 MPa the activity loss was not 
significant, the shearing forces probably remained low because the single pellets did not break and 
only slightly changed their shape.  
 
The behavior of all investigated β-galactosidase preparations concerning the activity loss under 
pressure is summarized in Fig. 5.46. 
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Fig. 5.46: Summary of the behavior of the activity under pressure of the investigated β-
galactosidase preparations.  
 
 
A comparison of the activity loss at maximum pressure and the K values of the investigated β-
galactosidase preparations is given in Tab. 5.5.  
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Tab. 5.5: Comparison of the activity at maximum pressure and the K values of the 
investigated β-galactosidase preparations. 
 
Preparation K  value (MPa-1) Activity at max. pressure (%)
Bulk β-galactosidase powder 0.00373 46.7
β-Galactosidase- 0.01318 75.9
microcrystalline cellulose
granulate
β-Galactosidase- 0.00785 61.2
dicalcium phosphate dihydrate
granulate
β-Galactosidase- 0.01507 89.3
microcrystalline cellulose 
pellets
β-Galactosidase- 0.01008 77.6
sugar
pellets
 
 
 
The investigation of the behavior of the activity under pressure of β-galactosidase powder, β-
galactosidase-microcrystalline cellulose granulate, β-galactosidase-dicalcium phosphate granulate, 
β-galactosidase-microcrystalline cellulose pellets and β-galactosidase-sugar pellets showed that 
the extent of activity loss was dependent on the compression properties characterized with the 
Heckel equation. Preparations with a brittle behavior demonstrated a higher activity loss. Besides, 
there was also found a further influence on the activity loss under pressure. Obviously the degree 
of activity loss is also influenced by the shape and the size of the compacted particles and pellets. 
The compression of regular shaped particles with a constant particle size showed no activity loss, 
above all if the individuality of the single particles, namely pellets gets preserved in spite of a slight 
particle deformation.  
 
 
5.6 Investigation of the critical mixture concentration 
 
The investigation of different β-galactosidase preparations showed positive influences of plastic 
properties on the activity of the compacted enzyme preparations. Since the β-galactosidase 
powder preparation demonstrated a brittle compression character, the coating of pellets or the 
production of granulates seemed to have the clear advantage of higher plasticity compared to the 
enzyme powder. Nevertheless it must be kept in mind that the preparation of granulates and the 
coating of pellets is an additional production step, which is time consuming and therefore also 
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expensive. Moreover during the production process there are various influences on the enzyme, 
which must be evaluated to exclude negative consequences.  
 
For that reason it seemed also important to investigate the influence of powder excipients mixed 
with the enzyme powder in various amounts to get information about formulations for direct 
compression. Characterization of the compression behavior of the β-galactosidase powder 
preparations and binary mixtures of it with a plastic and a brittle excipient, respectively (chapter 
5.3) showed different behavior for the various mixtures. The aim was to detect critical densities for 
every mixture where the behavior of the tablet density showed sudden changes. With that 
approach a critical mixture concentration should be found for both excipients and that information 
was supposed to help to define robust formulations for the compression of β-galactosidase powder 
with different excipients.  
 
 
5.6.1 Mixture with plastic excipient 
 
To characterize the behavior of β-galactosidase powder in binary powder mixtures, 10 mixtures 
with microcrystalline cellulose, a typical plastic excipient, were investigated.  
 
 
5.6.1.1 Critical densities 
 
The enzyme activity was analyzed as a function of the apparent density of the powder compact. 
The apparent density of a powder compact is a result of the applied maximum compaction 
pressure. As 100% of the enzyme activity was measured for the material before compression, it 
was necessary to find a suitable representation of the enzyme activity of the compact. For this 
reason the apparent density of the compact was normalized with the poured density of the material 
before compression. Thus for the normalized relative density ρn a value of 1 was obtained at an 
enzyme activity of 100% and therefore for the higher values of ρn the respective values of enzyme 
activity.  
 
The 11 curves obtained were approximated with two linear sections using Eq. (4.6) and each 
section was linearized by a regression line. The intersection of the two regression lines was 
determined as critical normalized density. This method for the identification of sudden changes in 
the behavior of a system was introduced and evaluated by Leu (1993). The relationship between 
activity and density of the compacts and the approximation with two linear sections for the mixtures 
investigated is shown in Fig. 5.47 and Fig. 5.48.  
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Fig. 5.47: Relationship between activity and density for binary β-galactosidase 
microcrystalline cellulose powder mixtures (amounts of 1-70% β-galactosidase).    
N = 5, error bars: ± 1 standard deviation.  
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Fig. 5.48: Relationship between activity and density for binary β-galactosidase 
microcrystalline cellulose powder mixtures (amounts of 80-100% β-galactosidase). 
N = 5, error bars: ± 1 standard deviation.  
 
 
An overview of the exact squared correlation coefficients R2 of the non-linear regression as well as 
the two linear sections is given in Tab. 5.6. 
 
 
Tab. 5.6: Squared correlation coefficients of the binary β-galactosidase microcrystalline 
cellulose mixtures. 
 
Amount of Squared correlation coefficient R 2
β-galactosidase (%) Non-linear Section 1 Section 2
regression
1 0.987 0.988 0.927
10 0.991 0.986 0.927
20 0.995 0.998 0.836
30 0.985 0.973 0.584
40 0.944 0.909 0.363
50 0.992 0.985 0.995
60 0.999 0.998 0.997
70 0.989 0.944 0.995
80 0.999 0.997 0.999
90 0.941 0.765 0.790
100 0.988 0.969 0.983
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Each curve approximated by two straight lines showed a clear bend. At higher compaction 
pressures, the degree of activity loss was more important. Several plots showed that the activity 
loss at very high compaction pressures depended only on the final apparent density of the compact 
(out-of-die). The partition of the curves resulted mainly between the compaction pressure of 199 
and 298 MPa, respectively. The mean squared correlation coefficient R2 of the regression lines of 
section 1 and section 2 was 0.956 (±0.0687) and 0.854 (±0.2068), respectively. The low value of 
the correlation coefficient of section 2, as well as the high standard deviation is a consequence of 
the quite constant values for the normalized density at high compaction pressures.  
 
Although there was a bend visible for every mixture ratio, the application of the evaluation method, 
namely the detection of the intersection of the two regression lines, showed some weaknesses. 
The problem was on the one hand the low number of data points and on the other hand the lack of 
data at low densities. Since it was necessary to get stable compacts for the out-of-die 
characterization and the detection of the enzyme activity it was not possible to generate data 
between compaction pressures of 0 and 40 MPa, because in this range stable compacts could not 
be produced. It is conceivable that in the region of the transition between the state of the powder 
and the state of the compact there is also a sudden change in the behavior of the enzyme activity, 
which was not detectable with the present experimental conditions. The second problem was the 
irregularities of the data caused by the enzyme itself. Differences in the denaturation of the 
molecules or small variations in the handling during the experiment can have big influences on the 
enzyme activity. Nevertheless with the detection of the intersection of the regression lines of the 
two sections the description of the deviation from linearity in the relationship between activity and 
density of the investigated compacts was possible.  
 
 
5.6.1.2 Percolation threshold 
 
The detected critical normalized densities of the various binary β-galactosidase microcrystalline 
cellulose powder mixtures have been plotted as a function of the amount of β-galactosidase (Fig. 
5.49). 
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Fig. 5.49: Critical normalized densities of each binary mixture of β-galactosidase with 
microcrystalline cellulose. 
 
 
The critical normalized densities as a function of the amount of β-galactosidase were again 
approximated by two straight lines. Thus the plot was divided into two sections with a squared 
correlation coefficient R2 of 0.842 for section 1 and 0.959 for section 2, respectively. The squared 
correlation coefficient R2 of the non-linear regression was 0.966. The intersection indicates the 
critical concentration of β-galactosidase for binary mixtures with microcrystalline cellulose. A value 
of 18.9% (w/w) was determined, corresponding 20.3% (V/V), i.e. roughly 20% (V/V). This critical β-
galactosidase concentration can be interpreted as the percolation threshold of this binary mixture 
system. It defines the point where the system dominance of microcrystalline cellulose is replaced 
by the dominance of the β-galactosidase powder preparation. It is evident that for amounts of β-
galactosidase >20% (V/V) a linear decrease of the critical normalized density is obtained with a 
slope being smaller than in the range <20% (V/V). The loss of activity of β-galactosidase was more 
important for enzyme concentrations below 20% (V/V), i.e. below the percolation threshold. Thus 
the question arises why the loss of enzyme activity is diminished above the percolation threshold. 
This behavior is probably due to the fact that β-galactosidase powder is brittle and microcrystalline 
cellulose powder is plastic. The brittle powder is percolating and builds a lattice in which the plastic 
powder is hindered to flow freely into the void space in between the brittle material. This seems to 
be favorable and reduces the loss of enzyme activity. In addition it is also conceivable that the 
rigidity of the lattice and the filling of the pore spaces with microcrystalline cellulose particles 
prevent the fracturing of the brittle particles and reduces therefore the shearing forces in the 
compact.  
 
Below the percolation threshold the enzyme powder is completely embedded in the microcrystalline 
cellulose powder. Interestingly, the loss of enzyme activity is more important in case of isolated 
isles of enzyme in a continuum of microcrystalline cellulose. Tablet density increases because the 
rigid lattice of the enzyme powder is destroyed and the tablet can be compacted to higher 
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densities, i.e. the tablet porosity is reduced and thus activity loss is increased. In addition the 
shearing forces are higher with a dominance of microcrystalline cellulose because the particle 
movement is bigger than in the lattice dominated by the brittle substance. Thus the plastic powder 
microcrystalline cellulose does not work as a protecting substance.  
 
The dependence of the activity loss on the tablet density and on the tablet porosity, respectively, of 
the different mixture ratios could also be proved comparing the different porosity curves. The 
porosity curve of each mixture was correlated separately with the porosity curve of bulk β-
galactosidase (Eq. (4.7)). Correlation values are shown in Fig. 5.50.  
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Fig. 5.50: Correlation of porosity curves of each mixture with the porosity curve of bulk β-
galactosidase.  
 
 
Correlation coefficients r of the porosity curves were very high, i.e. no value was lower than 0.95. 
But it is obvious that the correlation coefficients r of the mixtures with an amount of β-galactosidase 
powder smaller than 20% are lower than the other correlation coefficients. This means that there is 
a change in the porosity behavior of the compacts prepared with a mixture ratio below the 
percolation threshold. A comparison of the porosity curve with the corresponding activity curve of 
each mixture (Eq. (4.7)) showed also good correlation coefficients between 0.69 and 0.97 (Fig. 
5.51). 
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Fig. 5.51: Correlation of porosity and activity of each mixture.  
 
 
Although the values of the correlation coefficients r are spread over a wide range, there may not be 
found a systematic trend. The wider distribution can be explained by the quite high standard 
deviation values of the enzyme activity. So it can be stated that for each mixture the porosity 
correlated with the corresponding activity values. Since the porosity is dependent on the amount of 
β-galactosidase in the binary mixture, it could be shown that porosity is an important factor for the 
activity loss in the compacted enzyme powder.  
 
 
5.6.2 Mixture with brittle excipient 
 
To characterize the behavior of β-galactosidase powder in binary powder mixtures, 10 mixtures 
with dicalcium phosphate dihydrate, a typical brittle excipient, were investigated.  
 
 
5.6.2.1 Critical densities 
 
The enzyme activity was analyzed again as a function of the apparent density of the powder 
compact, normalized as described in chapter 5.6.1.1. The 11 curves obtained were approximated 
with two linear sections using Eq. (4.6) and each section was linearized by a regression line. The 
intersection of the two regression lines was determined as critical normalized density. The 
relationship between activity and density of the compacts and the approximation with two linear 
sections for the mixtures investigated is shown in Fig. 5.52 and Fig. 5.53.  
 
 
Results and Discussion 
 94  
 
 
Fig. 5.52: Relationship between activity and density for binary β-galactosidase dicalcium 
phosphate dihydrate powder mixtures (amounts of 1-70% β-galactosidase).           
N = 5, error bars: ± 1 standard deviation.  
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Fig. 5.53: Relationship between activity and density for binary β-galactosidase dicalcium 
phosphate dihydrate powder mixtures (amounts of 80-100% β-galactosidase).       
N = 5, error bars: ± 1 standard deviation.  
 
 
An overview of the exact squared correlation coefficients R2 of the non-linear regression as well as 
the two linear sections is given in Tab. 5.7. 
 
 
Tab. 5.7: Squared correlation coefficients of the binary β-galactosidase microcrystalline 
cellulose mixtures. 
 
Amount of Squared correlation coefficient R 2
β-galactosidase (%) Non-linear Section 1 Section 2
regression
1 0.995 0.985 0.999
10 0.996 0.999 0.982
20 0.981 0.970 0.946
30 0.990 0.993 0.927
40 0.974 0.983 0.783
50 - 0.950 1.000
60 0.996 0.992 0.987
70 0.999 0.998 0.998
80 0.989 0.980 0.928
90 0.999 0.999 0.992
100 0.990 0.949 0.999
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In the curves of these brittle-brittle mixtures there could also be seen clear bends. Again the degree 
of activity loss was more important at higher compaction pressures. The mean squared correlation 
coefficient R2 of the regression lines of section 1 and section 2 was 0.982 (±0.0182) and 0.958 
(±0.0648), respectively.  
 
Although a partition into two sections was possible for every curve, some weaknesses of the 
method have to be faced. Due to the small number of data points, some irregularities can influence 
the evaluation. Irregularities can probably be caused by some unsteadiness of the degree of 
denaturation in the enzyme molecules. Namely the detection of the intersection of the regression 
lines in the curves with an amount of β-galactosidase of 40 and 50%, respectively was difficult. In 
the latter curve section 2 is only built of two data points, because irregularities in this region made 
an inclusion of more data points impossible. The values for the critical normalized densities of 
these two mixtures must therefore be interpreted with caution.  
 
 
5.6.2.2 Percolation threshold 
 
The detected critical normalized densities of the various binary β-galactosidase dicalcium 
phosphate dihydrate powder mixtures have been plotted as a function of the amount of β-
galactosidase (Fig. 5.54). 
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Fig. 5.54: Critical normalized densities of each binary mixture of β-galactosidase with 
dicalcium phosphate dihydrate. 
 
 
Results and Discussion 
 97 
The critical normalized densities as a function of the amount of β-galactosidase could not be 
divided into two sections. In spite of some irregularities in this curve there could not be detected a 
clear change in the behavior of the mixtures concerning the critical densities. The deviation mainly 
at 50% (m/m) corresponding 62.6% (V/V) may not be interpreted due to the inaccurate detection of 
the critical density in that region (chapter 5.6.2.1). Nevertheless the striking irregularities in the 
binary brittle mixtures with amounts of β-galactosidase of 40 and 50% found in the plot of enzyme 
activity against the normalized apparent density can also be a hint to some changes occurring in 
these mixtures. Verification of this supposition can only be done with further studies.  
 
The definition of a percolation threshold for the mixtures with the two brittle substances β-
galactosidase and dicalcium phosphate dihydrate was not possible. Probably the properties of 
these two substances are too similar for what reason the detection of differences in the behavior of 
mixtures is very difficult or even impossible.  
 
 
5.7 Optimum formulation 
 
After the investigation of various formulations for the production of a solid enzyme powder 
preparation, a comparison of their compression behavior and the influence on the enzyme activity 
was done to make a proposal for an optimum formulation.  
 
The effective amount of β-galactosidase powder in tablets produced out of the two different kinds of 
granulates, the two different kinds of coated pellets and the bulk β-galactosidase preparation was 
compared. The absolute amount of units in the different tablets and the maximum activity loss 
between zero (0 MPa) and maximum (1194 MPa) compaction pressure applied were also 
compared. Tab. 5.8 summarizes the comparisons of these properties. The investigated powder 
mixtures were not taken into account as optimum formulations because there could not be found 
any improvement of the compression properties concerning the behavior of the enzyme activity 
compared to the bulk β-galactosidase powder preparation.  
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Tab. 5.8: Comparison of enzyme activity in tablets from different β-galactosidase 
preparations (1 tablet = 100±0.5 mg). 
 
Compacted substance Effective amount Activity of uncompacted Activity loss 
of β-galactosidase substance (units/tablet) between 
powder / tablet (mg) 0-1194 MPa (%)
Bulk β-galactosidase powder 100.0 434.4 59.7
β-Galactosidase- 8.9 97.6 27.2
microcrystalline cellulose
granulate
β-Galactosidase- 2.3 54.6 40.1
dicalcium phosphate dihydrate
granulate
β-Galactosidase- 6.3 73.2 9.0
microcrystalline cellulose 
pellets
β-Galactosidase- 10.9 60.6 17.7
sugar
pellets
 
 
 
The total amount of units per tablet varied very much. On the one hand the amount of enzyme 
powder sprayed on the powders and pellets was different, on the other hand the increase in 
enzyme activity during the spraying process varied with the different substances produced. The 
highest amount of units per tablet was of course found in the β-galactosidase powder tablet. But 
there was also the highest degree of activity loss measured with the compacted powder. Although 
the activity of the uncompacted β-galactosidase-microcrystalline cellulose pellets was not very high 
it is supposed to be the best formulation because the activity loss was low, what simplifies the 
validation of the formulation. That suggestion is based on the concrete results of this work with its 
special experimental conditions.  
 
For a more general assessment there must be taken into account some practical aspects, too. If 
the enzyme preparation would be produced for some pharmaceutical use, it has to be checked if 
the necessary dosage can be reached within the compaction of coated pellets in a dosage unit with 
a pleasant size. Furthermore the costs of an additional process like pellet coating must be 
calculated and judged. The need or the occupation of an additional production facility as well as 
further factors like energy consumption, raw materials (pellet cores), time and manpower used can 
make such processes very expensive. These considerations indicate the preference of the direct 
compression of the β-galactosidase powder preparation. But it has to be kept in mind that the 
compression in this work was done with a material testing machine in which every tablet was 
compacted individually. The compression of brittle powders in a rotary press is known to be difficult 
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and even the compression of pellets could cause some problems. For that reason the optimum 
formulation from a practical point of view could also be the compression of the β-galactosidase-
microcrystalline cellulose granulate. That plastic granulate showed the highest enzyme activity in 
the uncompacted state beside the bulk enzyme powder and due to the plastic properties the 
activity loss was also smaller than within the bulk β-galactosidase powder. The economic aspects 
are the same as discussed for the pellet preparation, though. Hence it can be said that, although a 
lot of clarification can be done by research work, there is still needed some practice oriented 
development and there can be very different points of view defining an optimum formulation.  
 
 
5.8 Validity for other enzyme powders 
 
This work is limited on the investigation of one model enzyme. Of course the question arises if the 
results do also have validity for other enzyme preparations. Solid enzyme products are normally 
lyophilized powders and thus mixtures of pure enzyme, excipient and buffer salts. As a 
consequence the behavior of the enzyme powder under compression is dependent on the special 
composition. With the definition of the special compression properties of an enzyme powder 
preparation the product can be characterized. For similar compression properties there are 
expected similar effects on the enzyme activity, also in combination with compression excipients. 
The following chapter is a first step into the direction of testing the applicability of the results on 
another enzyme preparation. Of course further investigation will be necessary to get based 
evidence on that problem.  
 
 
5.8.1 Comparison with a second enzyme powder preparation 
 
In collaboration with a small pharmaceutical company (Meristem Therapeutics, Clermont-Ferrand, 
France), an enzyme powder preparation, which is going to be launched to market was investigated. 
Bulk enzyme powder was compressed as well as several mixtures of it with an excipient. The 
enzyme product was again a lyophilized powder with a composition of 40% enzyme, 10% buffer 
salts and 50% lactose. To exclude influences of further excipients, lactose was used to produce 
mixtures with the enzyme preparation in amounts of 1, 10, 20, 30, 40, 50, 60, 70, 80 and 90% of 
the enzyme powder preparation. The compaction conditions were the same as applied for the β-
galactosidase enzyme powder (chapter 4.6), i.e. the production of tablets with a weight of 100 mg 
with an 8 mm-diameter punch. The compaction pressures had to be adapted and compacts were 
produced at 10, 20, 40, 100, 140, 199, 298 and 398 MPa (corresponding 0.5, 1, 2, 5, 7, 10, 15 and 
20 kN). The enzyme activity of the produced compacts was measured by the company itself and 
only compacts compressed at 10, 100, 199 and 398 MPa of the following mixture ratios: 1, 10, 40, 
50, 60, 70, 80, 90 and 100% have been investigated. The enzyme powder preparation and the 
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excipient lactose were characterized as described in chapter 4.1 and their properties are 
summarized in Tab. 5.9. 
 
 
Tab. 5.9: Characterization of the substances. 
 
Substances Densities Mean 
True Poured ρ p particle 
(g/ml) (g/ml) (rel) size (µm)
Enzyme powder 1.60 0.043 0.027 209.1
Lactose 1.55 0.490 0.317 97.9
 
 
 
The compression behavior was characterized with Heckel equation (Eq. (3.3)) and the Heckel plots 
of the bulk enzyme powder preparation, lactose and a 50% mixture of these two substances is 
shown in Fig. 5.55. 
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Fig. 5.55: Heckel plots of bulk enzyme powder preparation and lactose and their mixture 
(50:50). 
 
 
The two bulk substances showed similar behavior in the Heckel plot and the K values described 
brittle behavior with 0.00386 MPa-1 (R2 = 0.843) for the enzyme powder preparation and 0.00440 
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MPa-1 (R2 = 0.956) for lactose. The K value of the 50% mixture of the bulk substance showed 
positive deviation with 0.00663 MPa-1 (R2 = 0.610). It is to mention that the enzyme powder 
preparation was very fluffy and the irregularities in the curve could be caused by the special nature 
of the particles.  
 
The behavior of the yield strength (Eq. (3.5)) of the mixture is shown in Fig. 5.56. 
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Fig. 5.56: Yield strength of the mixtures of bulk enzyme powder preparation and lactose.  
 
 
Although the bulk substances show brittle behavior the mixtures show tendencies towards plastic 
properties, especially in mixtures with amounts of enzyme powder between 20 and 50%. This 
behavior is contrary to the behavior of the mixtures from the other brittle substances investigated, 
namely β-galactosidase enzyme powder and dicalcium phosphate dihydrate, which showed brittle 
behavior over the whole mixture range investigated. This deviation towards a plastic behavior can 
probably be explained by the special fluffy nature of the enzyme powder particles.  
 
The activity detected in compacts compressed at maximum compaction pressure (398 MPa) was 
89.5% at a porosity of 12.8% for the bulk enzyme powder preparation. The enzyme activity of the 
compacts of the different mixtures was analyzed as a function of the apparent density of the 
powder compact, normalized as described in chapter 5.6.1.1. The curves were approximated with 
two linear sections using Eq. (4.6) and each section was linearized by a regression line. The 
intersection of the two regression lines was determined as critical normalized density.  
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The problem in this special case was the very low number of data points and the big irregularities in 
the curves. It is not possible to make basic statements of a partition of five data points into two 
sections because in any case one section will consist only of two data points. Moreover, if the 
irregularities of the curves have been too big, a linearization of two sections was impossible. The 
critical density was then determined as the data point where no more big changes in density of the 
compacts occurred. This procedure could not be evaluated and the interpretation of the whole 
number of data is in this case questionable. Nevertheless the defined critical densities were plotted 
against the amount of enzyme powder preparation (Fig. 5.57) to judge the tendencies of the 
system to build critical concentrations over the mixture range.  
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Fig. 5.57: Critical densities of each binary mixture of enzyme powder preparation with 
lactose. 
 
 
The curve showed a deviation at a mixture range of 60%, but it is not sure if this deviation can be 
associated with an outlier or a critical concentration, i.e. a true change in the behavior of the 
system. In addition there cannot be given any statement on the behavior of amounts of enzyme 
powder preparation between 10 and 40% because there was no information on the enzyme activity 
in these compacts. Nevertheless the value of 60% for a critical concentration in mixtures with two 
brittle substances would be consistent with the results found in chapter 5.6.2.2 but in both cases 
the results can not really be judged due to the lack of data points and problems with the evaluation. 
Further investigations in that area would be interesting. 
 
The comparison of the enzyme powder preparation from a pharmaceutical company to the model 
enzyme investigated in this work did not lead to a reliable result. The small amount of data does 
not allow any conclusive assessment of the comparison. 
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6 Conclusion 
 
The investigated model enzyme β-galactosidase was influenced by different factors. The activity of 
the enzyme was positively influenced by temperatures up to 80°C in the solid state and up to 50°C 
dissolved in buffer solution. The presence of the binding agent hydroxy propyl methylcellulose in 
the solution had a stabilizing effect on the enzyme and led to an increased activity compared to the 
activity of enzyme powder dissolved in aqueous buffer solution. The increased viscosity in solutions 
with hydroxy propyl methylcellulose has probably a positive effect on the conformational rigidity of 
the enzyme molecule and may protect it from hydrolytic covalent reactions. This effect had also a 
big influence on the layering of powder, i.e. granulation and the coating of pellets. The products 
showed an increased activity, which was due to the temperature development during the spraying 
process and the presence of binding agent in the spraying solution. The quality of the film on the 
granulates and pellets was dependent on the porosity of the raw material. Fast elimination of water 
by absorption of the raw material caused rough surfaces, which showed lower activity increase 
than the smooth surfaces.  
 
The enzyme activity was negatively influenced by application of compaction pressure, whereas the 
extent of the activity loss was dependent on the compression character of the compacted 
substances. The characterization of the β-galactosidase powder preparation after Heckel (1961a, 
b) indicated brittle powder behavior, which was proved in comparison with the plastic model 
excipient microcrystalline cellulose and the brittle model excipient dicalcium phosphate dihydrate. 
Binary mixtures of the enzyme powder preparation with the plastic and the brittle excipient, 
respectively showed deviations from linearity. The yield strength of the various mixtures showed a 
dominance of the plastic excipient in the plastic-brittle mixtures below a concentration of 70% of 
brittle enzyme powder. The yield strength of the brittle-brittle mixtures showed no changes in 
deformation behavior over the whole mixture ranges. Thus similarity in the general behavior of two 
substances can make the definition of variations between the two substances difficult.  
 
The compression behavior of powders was partly influenced by the layering with enzyme powder 
solution and the consequently forming of agglomerates. The produced granulate from dicalcium 
phosphate dihydrate showed a more plastic behavior compared to its brittle raw material. The 
plastic behavior of the raw material microcrystalline cellulose at the contrary, was not further 
improved in the β-galactosidase-microcrystalline cellulose granulate. The extent of activity loss in 
the enzyme powder and the two granulates under pressure seemed to be dependent on the 
compression character of the preparation, whereas the activity loss in the brittle powder was the 
highest and the activity loss in the β-galactosidase-microcrystalline cellulose granulate, which was 
more plastic than the β-galactosidase-dicalcium phosphate dihydrate granulate was the lowest.  
 
Pellets from plastic raw material microcrystalline cellulose and from brittle raw material sugar 
showed both plastic behavior, which was not influenced by the coating with β-galactosidase 
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powder solution. Although the compression character was the same for both enzyme pellet 
preparations there was a difference in the extent of activity loss detectable. The pellets from the 
raw material microcrystalline cellulose did not show significant activity loss over the whole 
compression range, whereas the β-galactosidase-sugar pellets showed a slight activity loss 
compared to the activity loss in the enzyme granulates and the enzyme powder. The assessment 
of the behavior of the pellets in the compact with scanning electron microscopy pictures led to the 
conclusion that not only the compression character of the product is decisive for the extent of 
activity loss but also the shape and the size of the various particles. The fact that the β-
galactosidase-microcrystalline cellulose pellets did not break and only slightly changed their shape 
eliminating the spaces in the compact led to very low shearing forces. The β-galactosidase-sugar 
pellets also did not break but showed cracks in the surfaces of the various pellets. For that reason 
there were built small powder particles causing a higher number of shearing forces. The individual 
pellets only slightly changed their shape as well but the surfaces fused due to the cracking and 
therefore the activity loss was slightly higher for the β-galactosidase-sugar pellets than for the β-
galactosidase-microcrystalline cellulose pellets. Nevertheless the regular shape and size of the 
pellets seemed to have positive influence on the extent of activity loss under pressure due to the 
reduced number of shearing forces.  
 
Binary powder mixtures of the β-galactosidase preparation with the plastic excipient 
microcrystalline cellulose did not generally improve the behavior of the enzyme activity under 
pressure. It is supposed that over a wide mixture range the brittle enzyme powder dominates the 
system and builds a rigid lattice in which the plastic excipient is allowed to flow freely. The plastic 
deformation is in that case limited on the particles of the excipient. The plastically deformed 
particles can therefore fill up the free spaces in the lattice and prevent the brittle particles from 
fracturing, what reduces the shearing forces in the compact. With higher amounts of plastic 
excipient the lattice of the enzyme powder gets destroyed and microcrystalline cellulose dominates 
the system. Probably the dominant particles do not protect the brittle behavior with their plastic 
deformation but they do possibly crush the particles of the enzyme powder and cause therefore 
high shearing forces on the enzyme. The percolation threshold, i.e. the change in the system 
dominance was found to be at a mixture ratio of 20% of β-galactosidase enzyme powder. This 
mixture range should therefore be avoided to get robust formulations because at that mixture range 
a sudden change in the behavior of the system occurs. Moreover amounts of microcrystalline 
cellulose higher than 80% do have negative influences on the shearing forces in the compact and 
therefore on the activity of the enzyme powder. The expected protecting effect of the plastic 
excipient on the brittle β-galactosidase enzyme powder was therefore not found.  
 
Binary powder mixtures of the β-galactosidase preparation with the brittle excipient dicalcium 
phosphate dihydrate had no effect on the activity under compression compared to the activity loss 
in bulk β-galactosidase powder. The compression behavior was brittle over the whole mixture 
ranges. A system dominance of the one or the other substance could not be detected, probably the 
two substances behaved too similar to find differences. A deviation from the general behavior of 
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the mixtures could be found at a mixture ratio of 50% (m/m), corresponding 62.6% (V/V), but it 
could not be proved if this deviation was caused by an outlier or if it was a true percolation 
threshold. Further investigation on brittle-brittle powder mixtures in that mixture range would 
therefore be interesting, although a protecting effect on the enzyme activity in this range is not 
expected.  
 
A comparison with a second enzyme powder preparation, which had also a brittle compression 
behavior in mixtures with a brittle excipient could not help to find a clear characterization of the 
compression behavior of brittle-brittle mixtures. Again there was a deviation found at a mixture 
range of 60% of enzyme powder preparation, but due to a very low number of data, it was again 
impossible to associate the deviation to an outlier or to a true percolation threshold.  
 
The problem in the characterization of powder mixtures is the fact that there can only be described 
a general behavior. This behavior can be judged and interpreted. But it is difficult to really prove 
these interpretations because the compression behavior is always influenced by the character, the 
size and the shape of the particles. Moreover binary powder mixtures are influenced by the 
character, the size and the shape of the two different powders and by the interaction between 
them. The fact that the behavior of the activity under compression could not be improved with 
powder mixtures led to the conclusion that the interaction between the two kinds of particles is 
important. Particles do always interact under compression, they change their shape by deformation 
or do break, which causes shearing forces, friction or even wedging. A further aspect is also the 
fact that particles that show a brittle behavior and get cut into small pieces can change their 
compression behavior if they reached a low size and may start flowing and deform plastically. It is 
evident that if there are two different kinds of particles the possibilities of interaction and variation 
are broad. Even if the difference in the size and shape of the particles is optimal because densest 
packaging can be reached by filling up the free spaces between bigger particles with some smaller 
particles, there are a lot of interactions due to the diversity of the particles. This is probably the 
reason why mixtures of the brittle β-galactosidase enzyme powder with a plastic excipient did not 
decrease the extent of activity loss under compression although it could be proved that plastic 
properties do generally improve the behavior of the enzyme activity. The fact that best results could 
be found in compacts from coated pellets supports that statement. The regular shaped and sized 
pellets with their smooth surface kept their individuality and did not break. For that reason there 
was a minimum number of interactions, friction and shearing forces. Therefore it is proposed to use 
particles with the most similar character, size and shape for the compression of enzyme powders.  
 
The more similar and regular shaped the compressed particles are, the more problems can arise in 
the production of stable compacts. In the case that both kinds of particles are similar, though but 
have brittle properties, not only the activity loss would be high due to the brittle compression 
character but the production of compacts would also lead to problems because brittle substances 
can badly be compacted in direct compression. For that reason the production of a plastic 
granulate by layering the raw powder excipient with an enzyme powder solution is proposed. The 
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compression of a granulate is less problematic and the plastic properties would have a good 
influence on the behavior of the enzyme activity under pressure. The particles of the granulate 
have the same character and a similar shape and size, thus there are only interactions between 
particles with similar properties. The similarity of the particles can even be improved if the granulate 
is fragmented and only a special fraction is used for compression. The absence of further different 
kinds of particles from excipients will reduce interaction and the number of negative influences like 
shearing forces and friction remains low.  
 
The optimum formulation suggested is the use of enzyme coated plastic pellets or a plastic enzyme 
layered granulate. To prove the applicability of these formulations for practical industrial use, the 
compression of these enzyme formulations should be transformed on a rotary press to investigate 
the influences of the higher compression speed and the different forces acting on the compacted 
material. Also the economic aspect would of course have an influence on the definition of an 
optimum formulation. The production of granulates and the coating of pellets are additional 
production steps which can be expensive. The costs of an additional production facility, the energy 
consumption, the need of raw material like pellet cores, the time and manpower used for 
production can be expensive. Furthermore the validation and the registration of an additional 
production step for the creation of an oral solid dosage form can be difficult and time consuming 
and therefore be also expensive. It is also necessary to check if the required dosage can be 
reached if the enzyme is only sprayed on a carrier. If this would not be the case for a special 
enzyme in a pharmaceutical application other formulation could be taken into account. Since the 
compression of enzyme powder is not proposed from the results in this work, the production of 
enzyme pellets from a plastic excipient with a low porosity would be a possibility. The amount of 
enzyme could be increased because in that case the whole pellet would consist of enzyme powder 
and not only the coating of the pellet.  
 
These considerations demonstrate the limits of this research work. The investigated topic is 
dominated by basic research and can only partly be directly transferred to the development of 
dosage forms. Basic research is done to understand different phenomena and behavior. The 
development of dosage forms, though is still empirical and based on experiences. Basic research 
work can help to clarify general problems and develop models for the characterization of 
phenomena. Nevertheless the influences and variations in pharmaceutical technology are very 
broad and a single research work like this thesis is only a step in this direction but empirical 
development can still not be replaced. Practical, economical and legal aspects are also often the 
loser in basic research work.  
 
A lot of new aspects in the field of particle compression have been discussed in this work. It was 
found that the shape and the size of the various particles may have big influences on friction and 
shearing forces. Shearing forces can cause a reduction of enzyme activity during the compression 
of an enzyme powder. The compression character of the particles showed influences on the extent 
of activity loss under pressure, whereas plastic properties are favorable to protect the enzyme.  
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This work is far from treating the topic of compression of enzyme powder in an exhaustive manner. 
First aspects have been discussed on the behavior of a model enzyme powder. It would be 
interesting to make comparisons with other enzyme types. It is possible that other enzyme 
molecules behave different under pressure or are differently influenced by temperature, excipients 
and other factors. It would be interesting to investigate an enzyme powder preparation with a 
plastic compression behavior and furthermore the behavior of binary mixtures with a plastic and a 
brittle excipient. Lyophilisation of a liquid enzyme preparation with different excipients to obtain 
brittle and plastic solid enzyme preparations from the same enzyme molecules would allow a very 
exact comparison of the influences of the compression character on the behavior of the enzyme 
activity. An important step towards the practical aspects would be the transformation of the 
compression on a rotary press or a compaction simulator (e.g. MCC PressterTM, Metropolitan 
Computing Corporation, New Jersey, USA) and the production and compaction of enzyme pellets 
to reach higher dosage of enzyme preparation per tablet and also to profit from the positive aspects 
of the compression of pellets detected in this work.  
Conclusion 
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1% β-galactosidase / 99% MCC 10% β-galactosidase / 90% MCC 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density  activity [%] 
            
2.00 0.634 71.2 2.00 0.624 80.0 
2.00 0.638 54.0 2.00 0.629 81.4 
2.00 0.652 65.9 1.99 0.636 79.3 
1.99 0.658 70.0 1.99 0.643 60.1 
1.99 0.656 67.7 1.99 0.646 72.9 
            
5.00 0.824 58.9 4.99 0.818 40.7 
5.00 0.831 53.4 4.99 0.811 55.9 
4.99 0.835 54.0 5.00 0.830 62.4 
4.99 0.831 56.1 4.99 0.833 55.5 
5.00 0.831 59.6 4.99 0.834 62.6 
            
7.00 0.886 52.3 7.00 0.865 57.0 
7.00 0.879 50.3 6.99 0.868 54.3 
6.99 0.884 58.1 7.00 0.874 53.2 
6.99 0.882 64.2 6.99 0.872 55.8 
6.99 0.885 51.1 6.99 0.874 52.9 
            
9.99 0.925 52.6 9.99 0.920 63.4 
9.99 0.926 57.1 9.99 0.914 58.3 
10.00 0.927 56.4 9.99 0.916 44.8 
10.00 0.924 61.5 9.99 0.925 50.5 
10.00 0.929 55.7 9.99 0.929 51.0 
            
15.00 0.943 43.0 14.99 0.952 45.0 
15.00 0.940 50.3 14.99 0.953 53.4 
15.00 0.957 45.5 14.99 0.950 51.7 
15.00 0.946 42.9 14.99 0.947 55.8 
15.00 0.944 34.3 14.99 0.940 49.7 
            
19.99 0.958 32.4 20.00 0.958 48.8 
19.99 0.960 43.1 19.99 0.961 45.0 
19.99 0.967 30.6 19.99 0.959 51.7 
19.99 0.950 28.4 20.00 0.969 44.1 
19.99 0.956 30.9 19.99 0.954 49.9 
            
40.00 0.961 32.3 40.00 0.966 44.7 
39.99 0.960 42.8 40.00 0.965 52.6 
40.00 0.964 37.0 39.99 0.971 43.5 
39.99 0.962 40.9 40.00 0.962 51.9 
40.00 0.958 36.1 40.00 0.966 50.0 
            
60.00 0.996 22.2 59.99 0.971 41.2 
60.00 0.986 26.3 60.00 0.972 41.2 
60.00 0.986 32.9 60.00 0.967 39.1 
60.00 0.983 37.2 59.99 0.905 41.7 
60.00 1.003 33.4 60.00 0.971 43.4 
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20% β-galactosidase / 80% MCC 30% β-galactosidase / 70% MCC 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.610 72.3 2.00 0.619 97.4 
2.00 0.621 80.0 2.00 0.626 96.7 
2.00 0.649 86.8 2.00 0.639 86.1 
2.00 0.640 83.3 2.00 0.642 89.1 
1.99 0.653 83.0 2.00 0.646 81.0 
            
4.99 0.821 63.4 5.00 0.813 71.0 
5.00 0.829 62.4 5.00 0.821 71.8 
5.00 0.842 73.7 4.99 0.823 68.6 
5.00 0.829 71.0 4.99 0.826 75.9 
4.99 0.838 74.3 4.99 0.820 70.5 
            
7.00 0.892 65.4 6.99 0.872 62.7 
7.00 0.893 73.3 6.99 0.872 69.1 
7.00 0.889 56.4 7.00 0.865 85.1 
7.00 0.896 67.2 6.99 0.878 87.0 
6.99 0.890 73.0 6.99 0.872 85.4 
            
10.00 0.895 58.4 10.00 0.906 57.5 
10.00 0.903 56.3 10.00 0.918 59.8 
10.00 0.899 63.6 10.00 0.889 47.1 
10.00 0.902 57.8 10.00 0.892 58.3 
10.00 0.914 53.5 10.00 0.899 55.8 
            
15.00 0.942 50.2 15.00 0.931 51.2 
15.00 0.953 53.5 15.00 0.937 51.1 
15.00 0.955 43.9 15.00 0.932 59.8 
15.00 0.949 57.5 15.00 0.945 61.2 
15.00 0.944 51.1 15.00 0.944 63.2 
            
20.00 0.951 45.8 20.00 0.956 56.3 
19.99 0.952 46.4 20.00 0.943 56.1 
20.00 0.959 46.6 20.00 0.951 62.7 
20.00 0.961 43.2 20.00 0.967 60.3 
19.99 0.964 53.3 20.00 0.956 60.7 
            
39.99 0.967 50.5 40.00 0.976 61.3 
40.00 0.964 49.0 40.00 0.968 60.8 
40.00 0.963 47.2 40.00 0.960 66.2 
40.00 0.964 50.3 40.00 0.966 65.8 
40.00 0.976 46.2 40.00 0.998 60.4 
            
60.00 0.973 46.5 60.00 0.964 44.6 
60.00 0.970 45.6 60.00 0.968 48.8 
60.00 0.972 54.2 60.00 0.964 47.2 
60.00 0.972 51.0 60.00 0.964 56.0 
60.00 0.973 50.5 60.00 0.975 48.7 
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40% β-galactosidase / 60% MCC 50% β-galactosidase / 50% MCC 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.638 85.5 2.00 0.635 69.6 
2.00 0.647 96.3 2.00 0.643 68.7 
2.00 0.656 81.9 2.00 0.647 67.5 
1.99 0.654 90.6 2.00 0.651 74.4 
1.99 0.662 89.5 2.00 0.657 72.0 
            
4.99 0.803 72.3 5.00 0.807 62.7 
4.99 0.822 63.4 5.00 0.812 65.2 
5.00 0.831 66.1 4.99 0.815 59.5 
4.99 0.826 66.2 5.00 0.813 76.9 
4.99 0.821 67.6 4.99 0.815 64.6 
            
7.00 0.871 58.2 6.99 0.859 70.4 
6.99 0.876 59.9 6.99 0.863 64.3 
6.99 0.875 66.3 6.99 0.863 67.1 
6.99 0.876 69.1 6.99 0.869 62.6 
6.99 0.874 76.7 6.99 0.867 61.0 
            
9.99 0.931 29.9 9.99 0.907 64.4 
9.99 0.911 56.3 9.99 0.905 68.7 
9.99 0.913 64.3 9.99 0.909 68.5 
9.99 0.904 41.6 9.99 0.910 61.9 
9.99 0.916 63.2 10.00 0.918 59.5 
            
15.00 0.939 61.6 15.00 0.937 58.2 
15.00 0.952 59.0 14.99 0.941 58.0 
15.00 0.945 63.0 15.00 0.935 59.2 
15.00 0.942 67.3 15.00 0.937 66.5 
15.00 0.955 62.8 15.00 0.931 73.3 
            
20.00 0.966 11.8 20.00 0.962 38.5 
20.00 0.969 13.9 20.00 0.953 44.8 
20.00 0.948 11.8 20.00 0.955 48.7 
20.00 0.953 50.5 20.00 0.961 46.2 
20.00 0.961 54.4 19.99 0.955 43.4 
            
39.99 0.976 54.8 40.00 0.980 43.1 
39.99 0.967 54.5 40.00 0.969 52.3 
39.99 0.973 53.2 40.00 0.956 50.4 
39.99 0.970 54.8 40.00 0.955 54.7 
40.00 0.963 55.6 40.00 0.965 53.8 
            
60.00 0.976 55.2 60.00 0.965 52.0 
60.00 0.974 57.3 60.00 0.969 46.9 
60.00 0.973 47.5 60.00 0.966 46.7 
60.00 0.975 61.8 60.00 0.985 47.0 
60.00 0.971 64.2 60.00 0.978 52.9 
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60% β-galactosidase / 40% MCC 70% β-galactosidase / 30% MCC 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.697 97.8 1.99 0.668 89.2 
2.00 0.702 86.8 1.99 0.674 83.6 
1.99 0.684 80.5 1.99 0.673 87.5 
1.99 0.693 99.2 1.99 0.680 87.5 
1.99 0.702 102.3 1.99 0.678 86.4 
            
4.99 0.865 75.2 5.03 0.779 83.0 
4.99 0.838 71.8 5.02 0.770 73.5 
4.99 0.837 70.2 5.01 0.761 80.3 
4.99 0.827 65.2 5.01 0.752 76.2 
4.99 0.829 81.2 5.01 0.756 82.3 
            
6.99 0.885 73.0 7.05 0.820 62.6 
6.99 0.878 73.9 7.05 0.835 65.3 
6.99 0.885 74.5 7.01 0.816 87.6 
6.99 0.879 61.7 7.02 0.834 82.8 
6.99 0.881 74.9 7.10 0.831 89.9 
            
10.01 0.911 71.2 11.50 0.887 76.2 
10.12 0.914 72.6 10.01 0.888 75.7 
10.02 0.912 77.9 10.01 0.884 79.4 
10.02 0.916 69.4 10.00 0.883 65.4 
10.01 0.923 64.4 10.12 0.872 65.0 
            
15.02 0.964 59.4 15.00 0.932 59.3 
15.02 0.953 52.8 15.00 0.925 60.9 
15.01 0.939 54.0 15.00 0.921 62.6 
15.00 0.933 63.5 15.00 0.928 62.3 
15.01 0.934 66.7 15.03 0.921 72.7 
            
20.01 0.945 51.4 20.01 0.955 68.3 
20.02 0.946 40.0 20.00 0.936 59.2 
20.01 0.955 65.9 20.30 0.928 66.8 
20.02 0.977 57.2 20.00 0.960 61.5 
20.02 0.965 67.7 20.11 0.947 67.5 
            
40.01 0.963 65.6 40.00 0.961 31.9 
40.04 0.969 45.2 40.00 0.955 45.2 
40.03 0.988 48.7 40.00 0.964 41.1 
40.00 0.957 44.3 40.00 0.965 48.0 
41.57 0.979 48.8 40.00 0.959 44.8 
            
60.00 0.988 47.7 60.05 0.991 20.4 
60.00 0.998 53.1 60.06 0.963 19.7 
60.00 0.984 50.3 60.36 0.996 22.7 
60.00 0.994 49.0 60.04 0.970 21.3 
59.99 0.988 56.1 60.01 0.954 20.9 
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80% β-galactosidase / 20% MCC 90% β-galactosidase / 10% MCC 
            
comp. force [kN] rel.density activity[%] comp. force [kN] rel. density activity [%] 
            
1.99 0.696 78.4 2.00 0.635 94.4 
1.99 0.686 70.5 2.00 0.628 95.9 
1.99 0.686 89.3 2.00 0.640 100.9 
1.99 0.683 100.6 1.99 0.639 70.9 
1.99 0.688 84.7 2.00 0.654 94.4 
            
5.03 0.823 75.0 5.00 0.782 76.5 
5.00 0.808 75.6 5.02 0.779 76.5 
5.01 0.812 77.0 5.05 0.781 64.2 
5.03 0.817 78.1 5.02 0.776 74.3 
5.00 0.809 73.3 5.01 0.774 76.1 
            
7.01 0.848 72.7 7.00 0.819 65.2 
7.01 0.846 71.2 7.01 0.812 73.5 
7.00 0.836 78.2 7.03 0.824 64.4 
7.02 0.843 78.6 7.04 0.829 52.7 
7.00 0.838 75.2 7.00 0.819 63.7 
            
10.01 0.894 76.7 10.02 0.873 44.9 
10.03 0.907 65.4 10.02 0.873 46.8 
10.03 0.911 72.4 10.03 0.825 46.0 
10.01 0.903 72.8 10.01 0.833 48.3 
10.02 0.897 64.4 10.04 0.845 46.5 
            
15.01 0.932 64.5 15.01 0.903 50.8 
15.01 0.934 60.6 15.03 0.903 51.5 
15.01 0.933 66.6 15.03 0.916 53.6 
15.03 0.943 59.2 15.04 0.912 60.7 
15.02 0.936 62.6 15.01 0.912 39.9 
            
20.00 0.992 57.4 20.01 0.919 55.4 
20.00 0.984 51.5 20.01 0.931 60.3 
20.00 0.990 45.3 20.04 0.936 70.6 
20.00 0.974 50.8 20.02 0.922 55.2 
20.00 0.991 54.1 20.05 0.935 54.0 
            
40.02 0.975 68.1 40.02 0.941 51.5 
40.00 0.963 45.1 40.00 0.939 42.6 
40.01 0.964 44.5 40.03 0.939 50.4 
40.02 0.965 51.6 40.04 0.949 51.4 
40.03 0.959 51.5 40.03 0.941 49.9 
            
60.01 0.962 49.2 60.02 0.920 39.0 
60.03 0.970 43.8 60.07 0.935 31.0 
60.02 0.974 45.5 60.07 0.940 27.6 
60.03 0.979 49.9 60.02 0.939 43.1 
60.04 0.970 53.0 60.01 0.950 42.1 
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100% β-galactosidase / 0% MCC 1% β-galactosidase / 99% DCP 
            
comp. force [kN] rel.density activity[%] comp. force [kN] rel. density activity [%] 
            
2.00 0.732 94.2 2.00 0.690 71.9 
2.00 0.741 82.6 2.00 0.694 66.4 
1.99 0.746 92.9 2.00 0.696 76.0 
1.99 0.768 84.7 2.00 0.698 66.6 
2.00 0.773 90.4 2.00 0.696 71.9 
            
5.01 0.749 68.0 5.00 0.769 68.8 
5.01 0.749 73.6 5.00 0.762 56.1 
5.02 0.776 69.7 5.00 0.769 77.4 
5.15 0.786 77.8 5.00 0.760 74.3 
5.50 0.779 83.0 5.00 0.767 83.1 
            
7.05 0.812 68.7 7.00 0.778 60.2 
7.03 0.812 71.4 7.00 0.793 58.2 
8.20 0.828 74.2 7.00 0.782 56.5 
7.05 0.772 86.0 7.00 0.779 59.7 
7.03 0.831 79.5 7.00 0.786 49.2 
            
10.03 0.869 77.4 10.00 0.801 64.1 
10.03 0.887 71.0 10.00 0.800 56.8 
10.07 0.875 75.1 10.00 0.815 59.8 
10.06 0.871 66.9 10.00 0.810 60.1 
10.01 0.894 68.4 10.00 0.781 66.7 
            
15.02 0.904 62.8 15.00 0.803 46.7 
15.00 0.908 60.0 15.00 0.823 50.6 
15.03 0.921 64.5 15.00 0.809 49.0 
15.00 0.922 66.6 15.00 0.809 50.0 
15.00 0.909 55.9 15.00 0.832 55.0 
            
20.00 0.900 48.1 20.00 0.820 46.7 
20.02 0.913 52.2 20.00 0.832 49.6 
20.02 0.914 55.3 20.00 0.868 45.1 
20.01 0.917 57.5 20.00 0.868 49.0 
20.02 0.933 58.8 20.00 0.873 47.3 
            
40.05 0.927 49.8 40.00 0.916 29.2 
40.01 0.927 48.4 40.00 0.923 27.4 
40.01 0.930 47.1 40.00 0.909 26.3 
40.01 0.946 52.3 40.00 0.931 27.0 
40.02 0.947 50.7 40.00 0.943 27.1 
            
60.03 0.966 47.2 60.00 0.937 22.5 
60.44 0.958 53.9 60.00 0.943 21.1 
60.22 0.975 47.3 60.00 0.946 19.6 
60.05 0.986 50.4 60.00 0.961 24.6 
60.84 0.973 50.5 60.00 0.939 26.2 
 
 
 
Appendix 
 121 
10% β-galactosidase / 90% DCP 20% β-galactosidase / 80% DCP 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.691 60.7 2.00 0.671 70.9 
2.00 0.690 53.2 2.00 0.672 83.8 
2.00 0.694 61.8 2.00 0.674 78.7 
2.00 0.676 71.8 2.00 0.670 83.0 
2.00 0.685 76.3 2.00 0.676 77.2 
            
5.00 0.763 71.5 5.00 0.742 64.7 
5.00 0.766 57.8 5.00 0.748 75.1 
5.00 0.769 66.8 5.00 0.751 57.9 
5.00 0.764 64.7 5.00 0.741 72.0 
5.00 0.765 72.4 5.00 0.733 58.7 
            
7.00 0.775 50.4 7.00 0.778 55.1 
7.00 0.785 63.2 6.99 0.765 58.8 
7.00 0.792 62.8 7.00 0.776 54.7 
7.00 0.800 70.0 6.99 0.782 63.3 
7.00 0.800 69.6 6.99 0.789 63.3 
            
10.00 0.817 60.5 10.00 0.810 44.4 
10.00 0.820 67.2 10.00 0.828 57.2 
10.00 0.824 59.8 10.00 0.820 58.0 
10.00 0.818 59.1 10.00 0.820 55.0 
10.00 0.835 65.7 10.00 0.823 51.6 
            
15.00 0.859 48.7 15.00 0.862 61.1 
15.00 0.865 45.9 15.00 0.850 56.4 
15.00 0.854 50.7 14.99 0.855 50.2 
15.00 0.851 50.4 15.00 0.864 47.7 
15.00 0.838 53.0 15.00 0.860 51.8 
            
20.00 0.874 51.4 19.99 0.871 48.8 
20.00 0.866 50.2 20.00 0.885 53.3 
20.00 0.847 49.6 20.00 0.882 49.1 
20.00 0.884 48.4 20.00 0.878 51.3 
20.00 0.871 45.2 20.00 0.867 47.5 
            
40.00 0.911 32.0 40.00 0.900 20.6 
40.00 0.898 33.3 39.99 0.912 28.3 
40.00 0.885 33.1 40.00 0.912 29.8 
40.00 0.887 30.8 39.99 0.918 32.7 
40.00 0.889 32.4 40.00 0.922 36.0 
            
60.00 0.901 25.5 60.00 0.895 22.5 
60.00 0.924 29.8 60.00 0.916 26.3 
60.00 0.932 25.0 60.00 0.898 26.8 
60.00 0.914 23.4 60.00 0.889 25.0 
60.00 0.912 30.7 60.00 0.920 23.6 
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30% β-galactosidase / 70% DCP 40% β-galactosidase / 60% DCP 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.655 75.8 2.00 0.632 92.1 
2.00 0.673 59.7 2.00 0.645 83.1 
2.00 0.650 81.6 2.00 0.648 95.5 
2.00 0.667 82.0 2.00 0.657 78.7 
2.00 0.653 92.5 2.00 0.648 84.8 
            
5.00 0.761 71.0 5.00 0.714 74.4 
5.00 0.735 81.5 5.00 0.720 78.3 
5.00 0.735 89.6 5.00 0.716 89.1 
5.00 0.734 71.7 5.00 0.726 60.8 
5.00 0.767 50.4 5.00 0.734 87.4 
            
7.00 0.764 47.8 7.00 0.714 53.1 
7.00 0.770 51.2 7.00 0.740 63.3 
7.00 0.770 46.6 7.00 0.751 40.7 
7.00 0.768 54.8 7.00 0.751 62.3 
7.00 0.770 61.8 7.00 0.763 52.9 
            
10.00 0.818 58.7 10.00 0.790 56.1 
10.00 0.809 55.5 10.00 0.788 49.5 
10.00 0.817 57.6 10.00 0.795 56.2 
10.00 0.817 55.0 10.00 0.794 55.8 
10.00 0.815 55.2 10.00 0.795 45.7 
            
15.00 0.844 39.1 14.99 0.811 54.5 
15.00 0.838 44.0 14.99 0.829 45.0 
15.00 0.843 45.4 15.00 0.828 47.6 
15.00 0.838 35.5 14.99 0.824 57.2 
15.00 0.849 38.8 15.00 0.832 54.1 
            
20.00 0.854 44.4 20.00 0.856 46.9 
20.00 0.854 30.3 20.00 0.852 48.0 
20.00 0.866 42.6 20.00 0.858 42.3 
20.00 0.863 40.8 20.00 0.855 42.5 
20.00 0.861 43.7 20.00 0.861 47.9 
            
40.00 0.889 25.6 40.00 0.889 25.6 
40.00 0.897 28.1 40.00 0.885 29.4 
40.00 0.905 22.6 40.00 0.884 26.4 
40.00 0.889 24.1 40.00 0.878 23.1 
40.00 0.899 25.9 40.00 0.885 23.2 
            
59.99 0.920 25.8 60.00 0.895 26.8 
60.00 0.883 21.1 60.00 0.893 27.0 
60.00 0.884 16.0 60.00 0.903 27.1 
60.00 0.879 13.7 60.00 0.897 29.5 
60.00 0.879 19.1 60.00 0.897 34.0 
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50 % β-galactosidase / 50% DCP 60 % β-galactosidase / 40% DCP 
            
comp. force [kN] rel. density  activity [%] comp. force [kN] rel. density  activity [%] 
            
2.00 0.546 81.7 1.99 0.632 55.1 
2.00 0.654 89.8 1.99 0.649 80.4 
2.00 0.663 78.2 1.99 0.643 84.5 
2.00 0.642 81.7 1.99 0.645 83.1 
2.00 0.664 76.0 1.99 0.600 67.3 
            
5.00 0.713 87.7 5.00 0.646 76.4 
5.00 0.727 67.2 5.00 0.685 71.2 
5.00 0.724 91.0 5.00 0.702 70.3 
5.00 0.731 100.0 5.00 0.666 72.7 
5.00 0.725 91.1 5.00 0.694 79.7 
            
7.00 0.726 77.7 7.00 0.737 57.1 
7.00 0.733 75.8 7.00 0.724 48.6 
7.00 0.732 74.8 7.00 0.735 59.0 
7.00 0.741 82.5 7.00 0.742 53.7 
7.00 0.743 84.0 7.00 0.736 58.8 
            
10.00 0.766 89.0 9.99 0.790 53.9 
10.00 0.772 87.2 10.00 0.789 53.9 
10.00 0.778 85.5 10.00 0.788 54.4 
10.00 0.790 76.9 10.00 0.792 48.9 
10.00 0.791 92.7 10.00 0.791 64.0 
            
15.00 0.857 39.9 15.00 0.800 44.3 
15.00 0.858 28.0 15.00 0.813 44.0 
15.00 0.828 51.4 15.00 0.829 42.1 
15.00 0.844 35.5 14.99 0.805 46.1 
15.00 0.858 54.4 14.99 0.824 46.4 
            
20.00 0.846 47.2 20.00 0.854 33.7 
20.00 0.855 43.9 20.00 0.876 42.6 
19.99 0.848 44.5 20.00 0.834 44.0 
20.00 0.855 47.0 19.99 0.881 42.3 
20.00 0.852 43.4 19.99 0.879 40.7 
            
40.00 0.867 37.6 40.00 0.888 24.6 
40.00 0.878 38.8 40.00 0.883 27.1 
40.00 0.879 40.2 39.99 0.881 32.9 
40.00 0.876 43.7 40.00 0.878 30.3 
40.00 0.887 41.8 39.99 0.864 28.5 
            
60.00 0.890 37.8 60.00 0.879 34.5 
60.00 0.900 36.9 60.00 0.874 27.2 
60.00 0.885 42.2 60.00 0.876 30.9 
60.00 0.905 42.7 60.00 0.881 31.6 
60.00 0.890 37.3 60.00 0.865 33.6 
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70% β-galactosidase / 30% DCP 80% β-galactosidase / 20% DCP 
            
comp. force [kN] rel. density  activity [%] comp. force [kN] rel. density  activity [%] 
            
2.00 0.638 73.8 2.00 0.611 70.7 
2.00 0.634 80.0 2.00 0.642 67.7 
2.00 0.646 81.8 2.00 0.636 57.7 
2.00 0.655 67.5 1.99 0.656 74.5 
2.00 0.655 73.9 2.00 0.647 75.6 
            
5.00 0.707 60.2 5.00 0.710 72.4 
5.00 0.717 69.0 4.99 0.688 75.1 
5.00 0.721 72.1 5.00 0.712 72.2 
5.00 0.712 63.6 5.00 0.718 72.8 
5.00 0.713 64.3 4.99 0.717 77.1 
            
7.00 0.735 56.3 6.99 0.773 51.2 
7.00 0.737 63.6 6.99 0.777 60.5 
7.00 0.748 61.2 6.99 0.784 65.4 
7.00 0.746 65.5 6.99 0.792 61.7 
7.00 0.752 64.6 6.99 0.783 60.1 
            
10.00 0.799 54.6 10.00 0.777 61.9 
10.00 0.795 45.8 9.99 0.776 42.6 
10.00 0.789 57.1 9.99 0.776 62.1 
9.99 0.804 57.6 9.99 0.771 59.3 
10.00 0.791 58.1 9.99 0.814 57.7 
            
15.00 0.812 43.6 15.00 0.845 44.1 
15.00 0.811 44.6 15.00 0.846 53.0 
15.00 0.818 48.7 15.00 0.852 41.1 
15.00 0.817 42.4 14.99 0.859 51.2 
15.00 0.818 48.4 14.99 0.876 49.1 
            
19.99 0.818 31.3 20.00 0.812 29.2 
20.00 0.837 42.1 20.00 0.844 42.2 
19.99 0.859 43.3 20.00 0.808 37.6 
19.99 0.847 47.1 20.00 0.803 41.9 
19.99 0.860 49.1 20.00 0.818 43.5 
            
40.00 0.852 25.7 40.00 0.878 18.9 
40.00 0.848 32.4 40.00 0.894 29.1 
40.00 0.860 20.3 40.00 0.894 29.7 
40.00 0.851 26.8 40.00 0.894 33.4 
40.00 0.844 28.1 40.00 0.898 26.7 
            
60.00 0.879 24.8 60.00 0.859 18.9 
60.00 0.886 28.6 60.00 0.895 24.7 
60.00 0.885 28.5 60.00 0.875 27.8 
60.00 0.889 30.3 60.00 0.877 32.4 
60.00 0.897 29.5 60.00 0.886 40.8 
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90% β-galactosidase / 10% DCP 100% β-galactosidase / 0% DCP 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.647 66.6 1.99 0.660 80.1 
2.00 0.652 67.4 1.99 0.650 80.7 
1.99 0.654 60.7 1.99 0.678 62.9 
1.99 0.637 73.2 1.99 0.666 83.2 
1.99 0.637 68.5 1.99 0.684 81.6 
            
4.99 0.743 63.2 4.99 0.651 68.3 
4.99 0.729 65.7 4.99 0.768 73.5 
4.99 0.733 71.8 5.00 0.853 68.3 
4.99 0.730 76.3 5.00 0.854 70.8 
5.00 0.725 71.3 5.00 0.850 75.3 
            
6.99 0.763 55.7 7.00 0.890 40.1 
6.99 0.769 64.3 7.00 0.892 53.0 
6.99 0.760 68.2 6.99 0.888 57.8 
6.99 0.759 71.5 6.99 0.883 58.7 
6.99 0.766 72.8 6.99 0.886 53.7 
            
9.99 0.809 60.0 9.99 0.851 51.7 
10.00 0.813 57.3 9.99 0.852 51.3 
9.99 0.810 53.6 9.99 0.863 53.1 
9.99 0.818 46.0 9.99 0.870 56.8 
9.99 0.811 48.3 9.99 0.854 51.8 
            
14.99 0.822 49.8 14.99 0.885 52.8 
14.99 0.826 54.0 14.99 0.882 55.8 
14.99 0.836 50.3 14.99 0.885 59.6 
14.99 0.832 54.6 14.99 0.892 59.2 
14.99 0.831 45.1 14.99 0.899 52.3 
            
19.99 0.856 33.3 20.00 0.909 52.4 
19.99 0.869 46.7 19.99 0.915 51.7 
19.99 0.865 40.7 20.00 0.917 54.0 
19.99 0.870 40.8 19.99 0.910 50.1 
19.99 0.876 36.0 20.00 0.915 50.9 
            
40.00 0.889 24.6 39.99 0.902 39.9 
39.99 0.899 29.9 39.99 0.914 50.9 
39.99 0.894 31.5 40.00 0.918 52.8 
39.99 0.893 37.1 40.00 0.912 51.4 
40.00 0.898 32.5 39.99 0.918 62.4 
            
59.99 0.889 27.8 59.99 0.932 58.2 
59.99 0.888 34.0 60.00 0.939 51.9 
59.99 0.898 33.8 60.00 0.939 38.0 
60.00 0.902 32.4 60.00 0.939 37.6 
59.99 0.902 28.0 60.00 0.944 38.7 
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β-galactosidase-MCC granulate (series I)  β-galactosidase-MCC granulate (series II) 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.695 61.9 2.00 0.701 92.8 
1.99 0.700 78.1 2.00 0.700 84.3 
1.99 0.699 81.8 1.99 0.701 93.3 
1.99 0.696 79.6 1.99 0.704 91.6 
1.99 0.698 75.5 1.99 0.706 95.8 
            
5.00 0.870 86.0 4.99 0.897 91.6 
5.01 0.874 73.4 4.99 0.885 85.6 
5.00 0.875 66.4 4.99 0.888 96.8 
4.99 0.870 78.2 4.99 0.891 94.2 
4.99 0.870 82.2 4.99 0.885 90.3 
            
6.99 0.928 71.9 6.99 0.935 60.0 
6.99 0.928 79.4 6.99 0.943 86.0 
6.99 0.930 75.1 6.99 0.929 84.1 
6.99 0.926 70.5 6.99 0.936 85.2 
6.99 0.921 77.2 6.99 0.934 87.4 
            
9.99 0.959 72.4 10.00 0.958 85.9 
9.99 0.966 69.0 10.00 0.968 95.5 
9.99 0.965 65.7 10.00 0.962 80.7 
9.99 0.955 68.3 9.99 0.957 78.6 
9.99 0.966 71.6 10.00 0.966 90.6 
            
14.99 0.982 65.1 15.00 0.981 86.2 
14.99 0.991 55.0 15.00 0.995 87.8 
14.99 0.981 64.1 15.00 0.970 95.6 
14.99 0.984 64.7 15.00 0.975 93.6 
14.99 0.986 56.7 15.00 0.968 88.4 
            
19.99 0.972 62.3 19.99 0.978 88.7 
19.99 0.987 64.5 19.99 0.981 86.1 
19.99 0.984 70.3 20.00 0.980 84.6 
19.99 0.973 72.2 19.99 0.980 80.9 
19.99 0.991 73.1 19.99 0.985 76.5 
            
40.00 1.004 69.7 40.00 1.002 77.9 
40.00 1.001 57.7 40.00 0.999 73.6 
39.99 0.999 66.8 40.00 0.995 70.2 
40.00 0.991 69.4 40.00 0.998 78.8 
39.99 0.997 63.9 40.00 0.992 85.1 
            
59.99 1.007 68.7 60.00 0.999 99.6 
59.99 1.020 72.6 60.00 0.999 82.6 
60.00 1.009 70.1 59.99 1.001 74.0 
59.99 0.998 73.4 59.99 1.000 83.6 
60.00 0.997 66.4 59.99 0.999 67.9 
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β-galactosidase-DCP granulate (series I)  β-galactosidase-DCP granulate (series II) 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density  activity [%] 
            
2.00 0.762 80.4 2.00 0.751 97.7 
2.00 0.757 89.6 2.00 0.749 98.0 
1.99 0.747 90.2 2.00 0.740 93.7 
2.00 0.755 88.7 2.00 0.740 97.4 
2.00 0.747 80.5 1.99 0.742 86.3 
            
5.00 0.864 83.9 5.00 0.849 79.0 
5.00 0.859 84.5 5.00 0.837 72.3 
4.99 0.855 83.5 5.00 0.853 89.3 
5.00 0.854 68.0 5.00 0.848 81.9 
5.00 0.857 81.7 5.00 0.854 84.9 
            
6.99 0.903 74.0 7.00 0.897 59.1 
6.99 0.898 79.5 7.00 0.889 75.7 
6.99 0.900 70.8 6.99 0.892 75.9 
7.00 0.894 73.9 6.99 0.888 74.9 
6.99 0.889 88.4 6.99 0.885 78.5 
            
9.99 0.925 64.2 10.00 0.928 78.0 
10.00 0.929 72.5 10.00 0.924 77.0 
10.00 0.934 68.7 9.99 0.934 75.3 
10.00 0.928 77.6 9.99 0.916 76.1 
9.99 0.924 80.4 9.99 0.925 79.2 
            
14.99 0.960 69.1 15.00 0.949 72.9 
14.99 0.968 66.9 15.00 0.974 65.0 
14.99 0.960 71.8 14.99 0.965 59.5 
14.99 0.964 63.1 15.00 0.952 75.9 
14.99 0.960 70.3 15.00 0.956 73.0 
            
19.99 0.999 64.0 19.99 0.977 70.9 
20.00 0.978 65.1 19.99 0.971 56.2 
20.00 0.974 61.0 19.99 0.976 60.4 
19.99 0.984 64.9 19.99 0.992 54.9 
19.99 0.974 66.1 19.99 0.978 63.1 
            
39.99 1.009 71.6 39.99 1.016 56.0 
40.00 1.020 59.7 40.00 1.025 60.8 
39.99 1.023 62.3 39.99 1.012 64.9 
39.99 1.020 59.5 40.00 1.010 65.0 
39.99 1.020 68.9 39.99 1.013 65.0 
            
60.00 1.020 60.8 60.00 1.030 59.8 
60.00 1.026 61.8 60.00 1.016 61.9 
59.99 1.012 63.6 60.00 1.018 57.6 
60.00 1.019 64.3 59.99 1.021 57.7 
60.00 1.027 63.0 60.00 1.014 61.6 
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100% β-galactosidase-MCC pellets 50% β-galactosidase-MCC pellets / 
      50% MCC pellets 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
5.00 0.965 97.3 5.00 0.968 85.8 
5.00 0.949 98.6 5.00 0.968 91.5 
4.99 0.953 98.7 5.00 0.977 96.2 
4.99 0.962 98.3 4.99 0.982 88.0 
4.99 0.969 94.0 4.99 0.979 88.2 
            
5.99 1.021 94.6 5.99 1.003 95.5 
5.99 1.022 91.4 6.00 0.999 104.9 
5.99 1.031 91.2 5.99 0.993 80.9 
5.99 1.006 89.2 6.00 0.996 89.3 
5.99 1.025 95.4 5.99 0.999 85.4 
            
6.99 0.997 91.6 7.00 1.003 111.6 
6.99 1.002 81.2 6.99 1.009 70.5 
6.99 1.006 90.9 6.99 1.008 104.7 
6.99 1.003 104.0 6.99 1.007 102.5 
6.99 1.004 90.8 6.99 1.001 100.7 
            
9.99 1.035 95.1 9.99 1.030 104.4 
9.99 1.036 89.6 10.00 1.033 97.7 
9.99 1.029 89.9 9.99 1.039 105.3 
9.99 1.044 92.0 9.99 1.029 108.8 
9.99 1.040 77.8 9.99 1.030 98.6 
            
14.99 1.042 101.1 14.99 1.040 84.4 
14.99 1.049 98.1 15.00 1.040 87.1 
14.99 1.043 110.2 14.99 1.041 92.4 
14.99 1.039 95.5 15.00 1.045 98.6 
14.99 1.040 97.0 14.99 1.044 104.6 
            
19.99 1.050 89.9 19.99 1.045 92.7 
19.99 1.054 99.7 19.99 1.046 99.0 
20.00 1.056 96.6 19.99 1.043 94.1 
19.99 1.046 103.6 19.99 1.043 87.9 
19.99 1.047 102.5 20.00 1.040 83.1 
            
39.99 1.056 91.7 39.99 1.060 97.3 
39.99 1.055 90.7 40.00 1.055 94.3 
39.99 1.052 86.3 39.99 1.050 95.7 
39.99 1.060 86.5 40.00 1.052 84.1 
39.99 1.061 83.4 40.00 1.052 86.9 
            
59.99 1.067 90.3 59.99 1.070 96.4 
59.99 1.077 88.9 59.99 1.075 88.3 
59.99 1.067 86.0 59.99 1.066 86.6 
59.99 1.064 90.9 59.99 1.067 103.2 
59.99 1.066 90.4 59.99 1.067 98.0 
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β-galactosidase-sugar pellets (series I)   β-galactosidase-sugar pellets (series II) 
            
comp. force [kN] rel. density activity [%] comp. force [kN] rel. density activity [%] 
            
2.00 0.808 99.8 2.00 0.812 116.9 
1.99 0.807 93.4 2.00 0.807 114.7 
1.99 0.812 97.8 2.00 0.807 125.7 
1.99 0.811 92.2 1.99 0.807 121.4 
1.99 0.800 95.1 1.99 0.804 129.3 
            
5.00 0.912 66.0 4.99 0.909 124.2 
5.00 0.915 90.1 4.99 0.909 120.3 
5.00 0.907 87.4 4.99 0.900 113.3 
4.99 0.917 92.0 4.99 0.919 85.7 
4.99 0.912 91.4 4.99 0.920 92.4 
            
7.00 0.951 89.6 6.99 0.960 81.7 
6.99 0.962 80.1 6.99 0.960 78.5 
6.99 0.962 87.2 6.99 0.963 80.8 
6.99 0.964 87.0 6.99 0.959 83.2 
6.99 0.962 91.9 6.99 0.960 88.8 
            
9.99 0.992 93.8 9.99 0.991 72.7 
9.99 0.984 90.0 10.00 0.979 69.5 
9.99 0.987 87.9 9.99 0.996 79.5 
9.99 1.000 89.1 9.99 0.997 73.1 
9.99 1.001 73.5 9.99 0.989 87.6 
            
14.99 1.026 77.5 14.99 1.030 83.3 
14.99 1.034 74.7 14.99 1.024 87.4 
14.99 1.022 76.8 14.99 1.026 85.1 
15.00 1.024 75.1 14.99 1.027 87.9 
14.99 1.021 71.5 14.99 1.024 85.3 
            
19.99 1.043 76.4 20.00 1.036 80.9 
19.99 1.033 74.1 20.00 1.034 77.8 
19.99 1.043 81.7 19.99 1.039 86.8 
19.99 1.033 62.9 19.99 1.040 84.5 
19.99 1.047 77.7 20.00 1.041 84.1 
            
40.00 1.057 75.0 39.99 1.059 78.3 
40.00 1.047 67.5 39.99 1.055 81.6 
40.00 1.059 80.7 40.00 1.059 80.9 
40.00 1.046 85.7 40.00 1.055 80.5 
40.00 1.051 82.8 39.99 1.057 84.0 
            
60.00 1.067 80.9 60.00 1.045 82.6 
60.00 1.059 81.1 59.99 1.061 76.2 
60.00 1.051 70.6 60.00 1.050 82.5 
60.00 1.041 74.7 59.99 1.053 73.1 
60.00 1.050 77.7 59.99 1.053 75.9 
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